Industries > Pharma > Pharmaceutical Contract Manufacturing Market Report 2020-2030
Pharmaceutical Contract Manufacturing Market Report 2020-2030
Forecasts by Product Category (Pharmaceutical Product Manufacturing, Biological Product Manufacturing), by Drug Type (API Manufacturing, FDF Manufacturing), by API (Small Molecule, Large Molecule, High Potency API (HPAPI)), by FDF (Solid Dose Formulation, Liquid Dose Formulation, Injectable Dose Formulation, Other FDFs), by End-user (Big Pharma, Small & Mid-size Pharma, Generic Pharmaceutical Companies, Other End-users). PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios
Pharmaceutical Contract Manufacturing–our new study reveals trends, R&D progress, and predicted revenues
Where is the Pharmaceutical Contract Manufacturing market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 543 page report provides 700+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Pharmaceutical Contract Manufacturing Market. See how to exploit the opportunities.
Forecasts to 2030 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.
To access the data contained in this document please email contactus@visiongain.com
Discover sales predictions for the world market and submarkets
Product Category
• Pharmaceutical Product Manufacturing
• Biological Product Manufacturing
Drug Type
• API Manufacturing
• FDF Manufacturing
API
• Small Molecule
• Large Molecule
• High Potency API (HPAPI)
FDF
• Solid Dose Formulation
• Liquid Dose Formulation
• Injectable Dose Formulation
• Other FDFs
By End-User
• Big Pharma
• Small & Mid-size Pharma
• Generic Pharmaceutical Companies
• Other End-Users
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
– U.S.
– Canada
• Europe
– Germany
– France
– United Kingdom
– Italy
– Spain
– Rest of Europe
• Asia Pacific
– China
– Japan
– India
– Australia
– South Korea
– Rest of Asia Pacific
• Latin America
– Brazil
– Mexico
– Argentina
– Rest of Latin America
• Middle East and Africa
– Turkey
– Saudi Arabia
– South Africa
– UAE
– Egypt
– Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Pharmaceutical Contract Manufacturing Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Pharmaceutical Contract Manufacturing Market will surpass $xx million in 2020, our work calculates. We predict strong revenue growth through to 2030.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Pharmaceutical Contract Manufacturing Market report helps you
In summary, our 543 page report provides you with the following knowledge:
• Revenue forecasts to 2030 for Pharmaceutical Contract Manufacturing Market, with forecasts for Product Category, Drug Type, API, FDF, and End User, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2030 for 5 regional and 16 key national markets – See forecasts for the Pharmaceutical Contract Manufacturing market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 13 of the major companies involved in the Pharmaceutical Contract Manufacturing Market. Some of the company’s profiled in this report include Catalent Inc., Lonza Group AG, Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Mylan NV, AbbVie Inc., Piramal Enterprises Ltd, Consort Medical plc, Baxter International Inc, Alkermes Plc, Bayer AG, GlaxoSmithKline plc, and NIPRO CORPORATION.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Pharmaceutical Contract Manufacturing Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Pharmaceutical Contract Manufacturing Market Report 2020-2030: Forecasts by Product Category (Pharmaceutical Product Manufacturing, Biological Product Manufacturing), by Drug Type (API Manufacturing, FDF Manufacturing), by API (Small Molecule, Large Molecule, High Potency API (HPAPI)), by FDF (Solid Dose Formulation, Liquid Dose Formulation, Injectable Dose Formulation, Other FDFs), by End-user (Big Pharma, Small & Mid-size Pharma, Generic Pharmaceutical Companies, Other End-users). PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1 Report Overview
1.1 Scope of Report
1.2 Why You Should Buy This Report
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.6.1 Primary Research
1.6.2 Secondary Research
1.7 Market Evaluation & Forecasting Methodology
1.8 COIVD-19 Impact Recovery Pattern Analysis
1.8.1 V-Shaped Recovery
1.8.2 U-Shaped Recovery
1.8.3 W-Shaped Recovery
1.8.4 L-Shaped Recovery
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2 Executive Summary
2.1 Pharmaceutical Product Manufacturing Segment is Expected to Maintain its Dominance in the Global Market
2.2 COVID-19 Impact on Pharmaceutical Contract Manufacturing Market
3 Market Dynamics
3.1 Factors Affecting Growth
3.1.1 Product and Process Innovation
3.1.2 Continuing Focus on Productivity
3.1.3 Cost Savings
3.1.4 Risk Management
3.1.5 Stringent Regulations
3.1.6 Patent Expirations
3.1.7 Decreasing Research and Development Success Rates
3.2 Market Drivers
3.2.1 Increasing Demand of Biosimilars
3.2.2 Increased Focus on Orphan and Specialty Drugs
3.2.3 Generics: A Driver or Restraint?
3.2.4 Increasing Demand for Formulation Development Services
3.2.5 Bio/Pharmaceutical Manufacturers’ Move Toward Strategic Collaboration With Drug Delivery Technology Companies
3.3 Opportunities in the Global Market
3.3.1 Lack of Manufacturing and Packaging Capabilities
3.3.2 Pharma Companies Will Continue To Look For Ways To Cut Drug Costs
3.3.3 Need for New Drug Delivery Technologies
3.3.4 Chemical APIs Will Experience Resurgence after the Shift of Focus to Biological APIs
3.4 Growth Restrain
3.4.1 Backwards Integration for Generics Manufacturers
3.4.2 The US Generic Drug User Fee Act and API Manufacturing
3.5 Challenges in Contract Manufacturing
3.5.1 Challenges in Assessing the Market: Supply versus Demand
3.6 SWOT Analysis
3.7 Porter’s Five Forces Analysis
3.7.1 What are Porter Five (5) Forces
3.7.2 Threat of New Entrants (Low to Moderate)
3.7.3 Rivalry Among the Existing Players (High)
3.7.4 Bargaining Power of Suppliers (Low)
3.7.5 Threats from Substitute Products (Low to Moderate)
3.7.6 Bargaining Power of Buyers (High)
4 Global Pharmaceutical Contract Manufacturing Market
4.1 Industry Structure Overview
4.1.1 Pharmaceutical Landscape
4.1.2 Objectives of Outsourcing
4.1.3 Contract Manufacturing Types
4.1.4 Suitable Services Provider
4.1.5 Benefits of Outsourcing
4.1.6 Drawbacks of Outsourcing
4.1.7 Outsourcing
4.1.8 Core Capabilities of Contract Manufacturing Organization
4.1.9 Services Offered by Contract Manufacturing Organizations
5 Global Pharmaceutical Contract Manufacturing Market
5.1 Overview
5.1.1 Analysis of Market Status Before COVID-19
5.1.2 Analysis of Market V-Shaped Recovery Pattern
5.1.3 Analysis of Market W-Shaped Recovery Pattern
5.1.4 Analysis of Market U-Shaped Recovery Pattern
5.1.5 Analysis of Market L-Shaped Recovery Pattern
5.2 Regional Market Overview
5.2.1 Analysis of Market Status Before COVID-19
5.2.2 Analysis of Market V-Shaped Recovery Pattern
5.2.3 Analysis of Market W-Shaped Recovery Pattern
5.2.4 Analysis of Market U-Shaped Recovery Pattern
5.2.5 Analysis of Market L-Shaped Recovery Pattern
5.3 Product Category Market Overview
5.3.1 Analysis of Market Status Before COVID-19
5.3.2 Analysis of Market V-Shaped Recovery Pattern
5.3.3 Analysis of Market W-Shaped Recovery Pattern
5.3.4 Analysis of Market U-Shaped Recovery Pattern
5.3.5 Analysis of Market L-Shaped Recovery Pattern
5.4 Drug Type Market Overview
5.4.1 Analysis of Market Status Before COVID-19
5.4.2 Analysis of Market V-Shaped Recovery Pattern
5.4.3 Analysis of Market W-Shaped Recovery Pattern
5.4.4 Analysis of Market U-Shaped Recovery Pattern
5.4.5 Analysis of Market L-Shaped Recovery Pattern
5.5 API Contract Manufacturing Market Overview
5.5.1 Analysis of Market Status Before COVID-19
5.5.2 Analysis of Market V-Shaped Recovery Pattern
5.5.3 Analysis of Market W-Shaped Recovery Pattern
5.5.4 Analysis of Market U-Shaped Recovery Pattern
5.5.5 Analysis of Market L-Shaped Recovery Pattern
5.6 FDF Contract Manufacturing Market Overview
5.6.1 Analysis of Market Status Before COVID-19
5.6.2 Analysis of Market V-Shaped Recovery Pattern
5.6.3 Analysis of Market W-Shaped Recovery Pattern
5.6.4 Analysis of Market U-Shaped Recovery Pattern
5.6.5 Analysis of Market L-Shaped Recovery Pattern
5.7 End-User Market Overview
5.7.1 Analysis of Market Status Before COVID-19
5.7.2 Analysis of Market V-Shaped Recovery Pattern
5.7.3 Analysis of Market W-Shaped Recovery Pattern
5.7.4 Analysis of Market U-Shaped Recovery Pattern
5.7.5 Analysis of Market L-Shaped Recovery Pattern
6 Global Market Analysis by Product Category
6.1 Pharmaceutical Product Manufacturing Market Analysis by Region
6.1.1 Market Overview
6.1.2 Analysis of Market Status Before COVID-19
6.1.3 Analysis of Market V-Shaped Recovery Pattern
6.1.4 Analysis of Market W-Shaped Recovery Pattern
6.1.5 Analysis of Market U-Shaped Recovery Pattern
6.1.6 Analysis of Market L-Shaped Recovery Pattern
6.2 Biological Product Manufacturing Market Analysis by Region
6.2.1 Market Overview
6.2.2 Analysis of Market Status Before COVID-19
6.2.3 Analysis of Market V-Shaped Recovery Pattern
6.2.4 Analysis of Market W-Shaped Recovery Pattern
6.2.5 Analysis of Market U-Shaped Recovery Pattern
6.2.6 Analysis of Market L-Shaped Recovery Pattern
7 Global Market Analysis by Drug Type
7.1 Active Pharmaceutical Ingredient Manufacturing Market Analysis by Region
7.1.1 Market Overview
7.1.2 Analysis of Market Status Before COVID-19
7.1.3 Analysis of Market V-Shaped Recovery Pattern
7.1.4 Analysis of Market W-Shaped Recovery Pattern
7.1.5 Analysis of Market U-Shaped Recovery Pattern
7.1.6 Analysis of Market L-Shaped Recovery Pattern
7.2 Finished Dosage Form Products Manufacturing Market Analysis by Region
7.2.1 Analysis of Market Status Before COVID-19
7.2.2 Analysis of Market V-Shaped Recovery Pattern
7.2.3 Analysis of Market W-Shaped Recovery Pattern
7.2.4 Analysis of Market U-Shaped Recovery Pattern
7.2.5 Analysis of Market L-Shaped Recovery Pattern
8 Global Market Analysis by Active Pharmaceutical Ingredients Contract Manufacturing
8.1 API Small Molecule Manufacturing Market Analysis by Region
8.1.1 Analysis of Market Status Before COVID-19
8.1.2 Analysis of Market V-Shaped Recovery Pattern
8.1.3 Analysis of Market W-Shaped Recovery Pattern
8.1.4 Analysis of Market U-Shaped Recovery Pattern
8.1.5 Analysis of Market L-Shaped Recovery Pattern
8.2 API Large Molecule Manufacturing Market Analysis by Region
8.2.1 Analysis of Market Status Before COVID-19
8.2.2 Analysis of Market V-Shaped Recovery Pattern
8.2.3 Analysis of Market W-Shaped Recovery Pattern
8.2.4 Analysis of Market U-Shaped Recovery Pattern
8.2.5 Analysis of Market L-Shaped Recovery Pattern
8.3 High Potency API (HPAPI) Manufacturing Market Analysis by Region
8.3.1 Challenges and Opportunities in High Containment Manufacturing
8.3.2 Analysis of Market Status Before COVID-19
8.3.3 Analysis of Market V-Shaped Recovery Pattern
8.3.4 Analysis of Market W-Shaped Recovery Pattern
8.3.5 Analysis of Market U-Shaped Recovery Pattern
8.3.6 Analysis of Market L-Shaped Recovery Pattern
9 Global Market Analysis by Finished Dosage Form Contract Manufacturing
9.1 Solid Dose Formulation Manufacturing Market Analysis by Region
9.1.1 Market Overview
9.1.2 Analysis of Market Status Before COVID-19
9.1.3 Analysis of Market V-Shaped Recovery Pattern
9.1.4 Analysis of Market W-Shaped Recovery Pattern
9.1.5 Analysis of Market U-Shaped Recovery Pattern
9.1.6 Analysis of Market L-Shaped Recovery Pattern
9.2 Liquid Dose Formulation Manufacturing Market Analysis by Region
9.2.1 Market Overview
9.2.2 Nonsterile Formulations
9.2.3 Analysis of Market Status Before COVID-19
9.2.4 Analysis of Market V-Shaped Recovery Pattern
9.2.5 Analysis of Market W-Shaped Recovery Pattern
9.2.6 Analysis of Market U-Shaped Recovery Pattern
9.2.7 Analysis of Market L-Shaped Recovery Pattern
9.3 Injectable Dose Formulation Manufacturing Market Analysis by Region
9.3.1 Sterile Formulations
9.3.2 Analysis of Market Status Before COVID-19
9.3.3 Analysis of Market V-Shaped Recovery Pattern
9.3.4 Analysis of Market W-Shaped Recovery Pattern
9.3.5 Analysis of Market U-Shaped Recovery Pattern
9.3.6 Analysis of Market L-Shaped Recovery Pattern
9.4 Other FDF Dose Formulation Manufacturing Market Analysis by Region
9.4.1 Semi-Solid Dosage Forms
9.4.2 Advanced Drug Delivery Products
9.4.3 Market Overview
9.4.4 Analysis of Market Status Before COVID-19
9.4.5 Analysis of Market V-Shaped Recovery Pattern
9.4.6 Analysis of Market W-Shaped Recovery Pattern
9.4.7 Analysis of Market U-Shaped Recovery Pattern
9.4.8 Analysis of Market L-Shaped Recovery Pattern
10 Global Market Analysis by End-User
10.1 Big Pharmaceutical Contract Manufacturing Market Analysis by Region
10.1.1 Analysis of Market Status Before COVID-19
10.1.2 Analysis of Market V-Shaped Recovery Pattern
10.1.3 Analysis of Market W-Shaped Recovery Pattern
10.1.4 Analysis of Market U-Shaped Recovery Pattern
10.1.5 Analysis of Market L-Shaped Recovery Pattern
10.2 Small & Mid-size Pharmaceutical Contract Manufacturing Market Analysis by Region
10.2.1 Analysis of Market Status Before COVID-19
10.2.2 Analysis of Market V-Shaped Recovery Pattern
10.2.3 Analysis of Market W-Shaped Recovery Pattern
10.2.4 Analysis of Market U-Shaped Recovery Pattern
10.2.5 Analysis of Market L-Shaped Recovery Pattern
10.3 Generic Pharmaceutical Companies Contract Manufacturing Market Analysis by Region
10.3.1 Analysis of Market Status Before COVID-19
10.3.2 Analysis of Market V-Shaped Recovery Pattern
10.3.3 Analysis of Market W-Shaped Recovery Pattern
10.3.4 Analysis of Market U-Shaped Recovery Pattern
10.3.5 Analysis of Market L-Shaped Recovery Pattern
10.4 Other End-User Contract Manufacturing Market Analysis by Region
10.4.1 Analysis of Market Status Before COVID-19
10.4.2 Analysis of Market V-Shaped Recovery Pattern
10.4.3 Analysis of Market W-Shaped Recovery Pattern
10.4.4 Analysis of Market U-Shaped Recovery Pattern
10.4.5 Analysis of Market L-Shaped Recovery Pattern
11 North America Pharmaceutical Contract Manufacturing Market Analysis
11.1 North America Market in Terms of Value
11.1.1 Analysis of Market Status Before COVID-19
11.1.2 Analysis of Market V-Shaped Recovery Pattern
11.1.3 Analysis of Market W-Shaped Recovery Pattern
11.1.4 Analysis of Market U-Shaped Recovery Pattern
11.1.5 Analysis of Market L-Shaped Recovery Pattern
11.2 US Pharmaceutical Contract Manufacturing Market Analysis
11.2.1 Pharmaceutical Manufacturing in the US: Regulatory Oversight, 2019
11.2.2 Controlling Foreign Manufacturing Sites
11.2.3 Outsourcing and US Manufacturing Regulations
11.2.4 Increased Demand for Domestic API Manufacturing?
11.2.5 Analysis of Market Status Before COVID-19
11.2.6 Analysis of Market V-Shaped Recovery Pattern
11.2.7 Analysis of Market W-Shaped Recovery Pattern
11.2.8 Analysis of Market U-Shaped Recovery Pattern
11.2.9 Analysis of Market L-Shaped Recovery Pattern
11.3 Canada Pharmaceutical Contract Manufacturing Market Analysis
11.3.1 Analysis of Market Status Before COVID-19
11.3.2 Analysis of Market V-Shaped Recovery Pattern
11.3.3 Analysis of Market W-Shaped Recovery Pattern
11.3.4 Analysis of Market U-Shaped Recovery Pattern
11.3.5 Analysis of Market L-Shaped Recovery Pattern
11.4 North America Market Analysis by Product Category
11.4.1 Analysis of Market Status Before COVID-19
11.4.2 Analysis of Market V-Shaped Recovery Pattern
11.4.3 Analysis of Market W-Shaped Recovery Pattern
11.4.4 Analysis of Market U-Shaped Recovery Pattern
11.4.5 Analysis of Market L-Shaped Recovery Pattern
11.5 North America Market Analysis by Drug Type
11.5.1 Analysis of Market Status Before COVID-19
11.5.2 Analysis of Market V-Shaped Recovery Pattern
11.5.3 Analysis of Market W-Shaped Recovery Pattern
11.5.4 Analysis of Market U-Shaped Recovery Pattern
11.5.5 Analysis of Market L-Shaped Recovery Pattern
11.6 North America Market Analysis by API Contract Manufacturing
11.6.1 Analysis of Market Status Before COVID-19
11.6.2 Analysis of Market V-Shaped Recovery Pattern
11.6.3 Analysis of Market W-Shaped Recovery Pattern
11.6.4 Analysis of Market U-Shaped Recovery Pattern
11.6.5 Analysis of Market L-Shaped Recovery Pattern
11.7 North America Market Analysis by FDF Contract Manufacturing
11.7.1 Analysis of Market Status Before COVID-19
11.7.2 Analysis of Market V-Shaped Recovery Pattern
11.7.3 Analysis of Market W-Shaped Recovery Pattern
11.7.4 Analysis of Market U-Shaped Recovery Pattern
11.7.5 Analysis of Market L-Shaped Recovery Pattern
11.8 North America Market Analysis by End-User
11.8.1 Analysis of Market Status Before COVID-19
11.8.2 Analysis of Market V-Shaped Recovery Pattern
11.8.3 Analysis of Market W-Shaped Recovery Pattern
11.8.4 Analysis of Market U-Shaped Recovery Pattern
11.8.5 Analysis of Market L-Shaped Recovery Pattern
12 Europe Pharmaceutical Contract Manufacturing Market Analysis
12.1.1 The EU is the Leading Destination for Pharmaceutical Contract Manufacturing
12.1.2 Regulatory Aspects of Pharma Manufacturing in the EU
12.1.3 The European Commission Amends Annex 16
12.1.4 The Falsified Medicine Directive: Controlling API Imports
12.1.5 Biopharma Manufacturing Demand Will Rise
12.1.6 The EU Contract Manufacturing Market Forecast 2020-2030
12.2 Europe Market in Terms of Value
12.2.1 Analysis of Market Status Before COVID-19
12.2.2 Analysis of Market V-Shaped Recovery Pattern
12.2.3 Analysis of Market W-Shaped Recovery Pattern
12.2.4 Analysis of Market U-Shaped Recovery Pattern
12.2.5 Analysis of Market L-Shaped Recovery Pattern
12.3 Germany Pharmaceutical Contract Manufacturing Market Analysis
12.3.1 Germany: The Leading EU Destination for API and FDF Manufacturing
12.3.2 Demand for Contract Manufacturing in Germany
12.3.3 Analysis of Market Status Before COVID-19
12.3.4 Analysis of Market V-Shaped Recovery Pattern
12.3.5 Analysis of Market W-Shaped Recovery Pattern
12.3.6 Analysis of Market U-Shaped Recovery Pattern
12.3.7 Analysis of Market L-Shaped Recovery Pattern
12.4 France Pharmaceutical Contract Manufacturing Market Analysis
12.4.1 Analysis of Market Status Before COVID-19
12.4.2 Analysis of Market V-Shaped Recovery Pattern
12.4.3 Analysis of Market W-Shaped Recovery Pattern
12.4.4 Analysis of Market U-Shaped Recovery Pattern
12.4.5 Analysis of Market L-Shaped Recovery Pattern
12.5 UK Pharmaceutical Contract Manufacturing Market Analysis
12.5.1 Analysis of Market Status Before COVID-19
12.5.2 Analysis of Market V-Shaped Recovery Pattern
12.5.3 Analysis of Market W-Shaped Recovery Pattern
12.5.4 Analysis of Market U-Shaped Recovery Pattern
12.5.5 Analysis of Market L-Shaped Recovery Pattern
12.6 Italy Pharmaceutical Contract Manufacturing Market Analysis
12.6.1 Italy: Strong API Manufacturing Traditions
12.6.2 Revenue Forecast for the Italian Pharma Contract Manufacturing
12.6.3 Analysis of Market Status Before COVID-19
12.6.4 Analysis of Market V-Shaped Recovery Pattern
12.6.5 Analysis of Market W-Shaped Recovery Pattern
12.6.6 Analysis of Market U-Shaped Recovery Pattern
12.6.7 Analysis of Market L-Shaped Recovery Pattern
12.7 Spain Pharmaceutical Contract Manufacturing Market Analysis
12.7.1 Spain: How Will Demand for Manufacturing Services Grow?
12.7.2 Analysis of Market Status Before COVID-19
12.7.3 Analysis of Market V-Shaped Recovery Pattern
12.7.4 Analysis of Market W-Shaped Recovery Pattern
12.7.5 Analysis of Market U-Shaped Recovery Pattern
12.7.6 Analysis of Market L-Shaped Recovery Pattern
12.8 Rest of Europe Pharmaceutical Contract Manufacturing Market Analysis
12.8.1 Compliance with GMP in Russia
12.8.2 How Will Demand for Contract Manufacturing Grow in Russia to 2030?
12.8.3 Analysis of Market Status Before COVID-19
12.8.4 Analysis of Market V-Shaped Recovery Pattern
12.8.5 Analysis of Market W-Shaped Recovery Pattern
12.8.6 Analysis of Market U-Shaped Recovery Pattern
12.8.7 Analysis of Market L-Shaped Recovery Pattern
12.9 Europe Market Analysis by Product Category
12.9.1 Analysis of Market Status Before COVID-19
12.9.2 Analysis of Market V-Shaped Recovery Pattern
12.9.3 Analysis of Market W-Shaped Recovery Pattern
12.9.4 Analysis of Market U-Shaped Recovery Pattern
12.9.5 Analysis of Market L-Shaped Recovery Pattern
12.10 Europe Market Analysis by Drug Type
12.10.1 Analysis of Market Status Before COVID-19
12.10.2 Analysis of Market V-Shaped Recovery Pattern
12.10.3 Analysis of Market W-Shaped Recovery Pattern
12.10.4 Analysis of Market U-Shaped Recovery Pattern
12.10.5 Analysis of Market L-Shaped Recovery Pattern
12.11 Europe Market Analysis by API Contract Manufacturing
12.11.1 Analysis of Market Status Before COVID-19
12.11.2 Analysis of Market V-Shaped Recovery Pattern
12.11.3 Analysis of Market W-Shaped Recovery Pattern
12.11.4 Analysis of Market U-Shaped Recovery Pattern
12.11.5 Analysis of Market L-Shaped Recovery Pattern
12.12 Europe Market Analysis by FDF Contract Manufacturing
12.12.1 Analysis of Market Status Before COVID-19
12.12.2 Analysis of Market V-Shaped Recovery Pattern
12.12.3 Analysis of Market W-Shaped Recovery Pattern
12.12.4 Analysis of Market U-Shaped Recovery Pattern
12.12.5 Analysis of Market L-Shaped Recovery Pattern
12.13 Europe Market Analysis by End-User
12.13.1 Analysis of Market Status Before COVID-19
12.13.2 Analysis of Market V-Shaped Recovery Pattern
12.13.3 Analysis of Market W-Shaped Recovery Pattern
12.13.4 Analysis of Market U-Shaped Recovery Pattern
12.13.5 Analysis of Market L-Shaped Recovery Pattern
13 Asia-Pacific Pharmaceutical Contract Manufacturing Market Analysis
13.1.1 Demand Will Increase for Services in India and China
13.2 Asia-Pacific Market in Terms of Value
13.2.1 Analysis of Market Status Before COVID-19
13.2.2 Analysis of Market V-Shaped Recovery Pattern
13.2.3 Analysis of Market W-Shaped Recovery Pattern
13.2.4 Analysis of Market U-Shaped Recovery Pattern
13.2.5 Analysis of Market L-Shaped Recovery Pattern
13.3 Japan Pharmaceutical Contract Manufacturing Market Analysis
13.3.1 Pharmaceutical Manufacturing Regulations in Japan
13.3.2 The Pharmaceutical Affairs Law
13.3.3 Analysis of Market Status Before COVID-19
13.3.4 Analysis of Market V-Shaped Recovery Pattern
13.3.5 Analysis of Market W-Shaped Recovery Pattern
13.3.6 Analysis of Market U-Shaped Recovery Pattern
13.3.7 Analysis of Market L-Shaped Recovery Pattern
13.4 China Pharmaceutical Contract Manufacturing Market Analysis
13.4.1 Chinese Demand for Pharma Contract Manufacturing Services
13.4.2 Improved Manufacturing Regulations in China
13.4.3 Regulations for Excipients and Guidance for API Manufacturing
13.4.4 What Are the Consequences to Stricter Manufacturing Regulations in China?
13.4.5 Chinese CMOs Are Investing in Biopharma Manufacturing
13.4.6 China Pharma Contract Manufacturing Market
13.4.7 Analysis of Market Status Before COVID-19
13.4.8 Analysis of Market V-Shaped Recovery Pattern
13.4.9 Analysis of Market W-Shaped Recovery Pattern
13.4.10 Analysis of Market U-Shaped Recovery Pattern
13.4.11 Analysis of Market L-Shaped Recovery Pattern
13.5 India Pharmaceutical Contract Manufacturing Market Analysis
13.5.1 Regulatory Outlook for Indian Pharma Manufacturing
13.5.2 Stricter Quality Standards to Ensure Compliance with EU Rules
13.5.3 Domestic Manufacturing Dominates the Indian Pharma Market
13.5.4 Demand for Contract Manufacturing in India
13.5.5 Analysis of Market Status Before COVID-19
13.5.6 Analysis of Market V-Shaped Recovery Pattern
13.5.7 Analysis of Market W-Shaped Recovery Pattern
13.5.8 Analysis of Market U-Shaped Recovery Pattern
13.5.9 Analysis of Market L-Shaped Recovery Pattern
13.6 South Korea Pharmaceutical Contract Manufacturing Market Analysis
13.6.1 South Korea: Government Supported Growth
13.6.2 South Korea: Strict GMP Regulations
13.6.3 South Korea: Pharma Contract Manufacturing Market
13.6.4 Analysis of Market Status Before COVID-19
13.6.5 Analysis of Market V-Shaped Recovery Pattern
13.6.6 Analysis of Market W-Shaped Recovery Pattern
13.6.7 Analysis of Market U-Shaped Recovery Pattern
13.6.8 Analysis of Market L-Shaped Recovery Pattern
13.7 Australia Pharmaceutical Contract Manufacturing Market Analysis
13.7.1 Analysis of Market Status Before COVID-19
13.7.2 Analysis of Market V-Shaped Recovery Pattern
13.7.3 Analysis of Market W-Shaped Recovery Pattern
13.7.4 Analysis of Market U-Shaped Recovery Pattern
13.7.5 Analysis of Market L-Shaped Recovery Pattern
13.8 Rest of APAC Pharmaceutical Contract Manufacturing Market Analysis
13.8.1 Analysis of Market Status Before COVID-19
13.8.2 Analysis of Market V-Shaped Recovery Pattern
13.8.3 Analysis of Market W-Shaped Recovery Pattern
13.8.4 Analysis of Market U-Shaped Recovery Pattern
13.8.5 Analysis of Market L-Shaped Recovery Pattern
13.9 Asia-Pacific Market Analysis by Product Category
13.9.1 Analysis of Market Status Before COVID-19
13.9.2 Analysis of Market V-Shaped Recovery Pattern
13.9.3 Analysis of Market W-Shaped Recovery Pattern
13.9.4 Analysis of Market U-Shaped Recovery Pattern
13.9.5 Analysis of Market L-Shaped Recovery Pattern
13.10 Asia-Pacific Market Analysis by Drug Type
13.10.1 Analysis of Market Status Before COVID-19
13.10.2 Analysis of Market V-Shaped Recovery Pattern
13.10.3 Analysis of Market W-Shaped Recovery Pattern
13.10.4 Analysis of Market U-Shaped Recovery Pattern
13.10.5 Analysis of Market L-Shaped Recovery Pattern
13.11 Asia-Pacific Market Analysis by API Contract Manufacturing
13.11.1 Analysis of Market Status Before COVID-19
13.11.2 Analysis of Market V-Shaped Recovery Pattern
13.11.3 Analysis of Market W-Shaped Recovery Pattern
13.11.4 Analysis of Market U-Shaped Recovery Pattern
13.11.5 Analysis of Market L-Shaped Recovery Pattern
13.12 Asia-Pacific Market Analysis by FDF Contract Manufacturing
13.12.1 Analysis of Market Status Before COVID-19
13.12.2 Analysis of Market V-Shaped Recovery Pattern
13.12.3 Analysis of Market W-Shaped Recovery Pattern
13.12.4 Analysis of Market U-Shaped Recovery Pattern
13.12.5 Analysis of Market L-Shaped Recovery Pattern
13.13 Asia-Pacific Market Analysis by End-User
13.13.1 Analysis of Market Status Before COVID-19
13.13.2 Analysis of Market V-Shaped Recovery Pattern
13.13.3 Analysis of Market W-Shaped Recovery Pattern
13.13.4 Analysis of Market U-Shaped Recovery Pattern
13.13.5 Analysis of Market L-Shaped Recovery Pattern
14 Middle East & Africa Pharmaceutical Contract Manufacturing Market Analysis
14.1 Middle East & Africa Market in Terms of Value
14.1.1 Analysis of Market Status Before COVID-19
14.1.2 Analysis of Market V-Shaped Recovery Pattern
14.1.3 Analysis of Market W-Shaped Recovery Pattern
14.1.4 Analysis of Market U-Shaped Recovery Pattern
14.1.5 Analysis of Market L-Shaped Recovery Pattern
14.2 Turkey Pharmaceutical Contract Manufacturing Market Analysis
14.2.1 Turkey: Domestic Market to offer Huge Growth Opportunities
14.2.2 Turkey: An Important Hub for Global Pharma Companies
14.2.3 Drug Approvals Delaying Growth of the Turkey Pharma Market
14.2.4 Analysis of Market Status Before COVID-19
14.2.5 Analysis of Market V-Shaped Recovery Pattern
14.2.6 Analysis of Market W-Shaped Recovery Pattern
14.2.7 Analysis of Market U-Shaped Recovery Pattern
14.2.8 Analysis of Market L-Shaped Recovery Pattern
14.3 Saudi Arabia Pharmaceutical Contract Manufacturing Market Analysis
14.3.1 Analysis of Market Status Before COVID-19
14.3.2 Analysis of Market V-Shaped Recovery Pattern
14.3.3 Analysis of Market W-Shaped Recovery Pattern
14.3.4 Analysis of Market U-Shaped Recovery Pattern
14.3.5 Analysis of Market L-Shaped Recovery Pattern
14.4 South Africa Pharmaceutical Contract Manufacturing Market Analysis
14.4.1 Analysis of Market Status Before COVID-19
14.4.2 Analysis of Market V-Shaped Recovery Pattern
14.4.3 Analysis of Market W-Shaped Recovery Pattern
14.4.4 Analysis of Market U-Shaped Recovery Pattern
14.4.5 Analysis of Market L-Shaped Recovery Pattern
14.5 UAE Pharmaceutical Contract Manufacturing Market Analysis
14.5.1 Analysis of Market Status Before COVID-19
14.5.2 Analysis of Market V-Shaped Recovery Pattern
14.5.3 Analysis of Market W-Shaped Recovery Pattern
14.5.4 Analysis of Market U-Shaped Recovery Pattern
14.5.5 Analysis of Market L-Shaped Recovery Pattern
14.6 Egypt Pharmaceutical Contract Manufacturing Market Analysis
14.6.1 Analysis of Market Status Before COVID-19
14.6.2 Analysis of Market V-Shaped Recovery Pattern
14.6.3 Analysis of Market W-Shaped Recovery Pattern
14.6.4 Analysis of Market U-Shaped Recovery Pattern
14.6.5 Analysis of Market L-Shaped Recovery Pattern
14.7 Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market Analysis
14.7.1 Analysis of Market Status Before COVID-19
14.7.2 Analysis of Market V-Shaped Recovery Pattern
14.7.3 Analysis of Market W-Shaped Recovery Pattern
14.7.4 Analysis of Market U-Shaped Recovery Pattern
14.7.5 Analysis of Market L-Shaped Recovery Pattern
14.8 Middle East & Africa Market Analysis by Product Category
14.8.1 Analysis of Market Status Before COVID-19
14.8.2 Analysis of Market V-Shaped Recovery Pattern
14.8.3 Analysis of Market W-Shaped Recovery Pattern
14.8.4 Analysis of Market U-Shaped Recovery Pattern
14.8.5 Analysis of Market L-Shaped Recovery Pattern
14.9 Middle East & Africa Market Analysis by Drug Type
14.9.1 Analysis of Market Status Before COVID-19
14.9.2 Analysis of Market V-Shaped Recovery Pattern
14.9.3 Analysis of Market W-Shaped Recovery Pattern
14.9.4 Analysis of Market U-Shaped Recovery Pattern
14.9.5 Analysis of Market L-Shaped Recovery Pattern
14.10 Middle East & Africa Market Analysis by API Contract Manufacturing
14.10.1 Analysis of Market Status Before COVID-19
14.10.2 Analysis of Market V-Shaped Recovery Pattern
14.10.3 Analysis of Market W-Shaped Recovery Pattern
14.10.4 Analysis of Market U-Shaped Recovery Pattern
14.10.5 Analysis of Market L-Shaped Recovery Pattern
14.11 Middle East & Africa Market Analysis by FDF Contract Manufacturing
14.11.1 Analysis of Market Status Before COVID-19
14.11.2 Analysis of Market V-Shaped Recovery Pattern
14.11.3 Analysis of Market W-Shaped Recovery Pattern
14.11.4 Analysis of Market U-Shaped Recovery Pattern
14.11.5 Analysis of Market L-Shaped Recovery Pattern
14.12 Middle East & Africa Market Analysis by End-User
14.12.1 Analysis of Market Status Before COVID-19
14.12.2 Analysis of Market V-Shaped Recovery Pattern
14.12.3 Analysis of Market W-Shaped Recovery Pattern
14.12.4 Analysis of Market U-Shaped Recovery Pattern
14.12.5 Analysis of Market L-Shaped Recovery Pattern
15 Latin America Pharmaceutical Contract Manufacturing Market Analysis
15.1 Latin America Market in Terms of Value
15.1.1 Analysis of Market Status Before COVID-19
15.1.2 Analysis of Market V-Shaped Recovery Pattern
15.1.3 Analysis of Market W-Shaped Recovery Pattern
15.1.4 Analysis of Market U-Shaped Recovery Pattern
15.1.5 Analysis of Market L-Shaped Recovery Pattern
15.2 Brazil Pharmaceutical Contract Manufacturing Market Analysis
15.2.1 Pharmaceutical Manufacturing Regulations in Brazil
15.2.2 Brazil Imports Most of its APIs
15.2.3 Brazil: Pharma Contract Manufacturing Market
15.2.4 Analysis of Market Status Before COVID-19
15.2.5 Analysis of Market V-Shaped Recovery Pattern
15.2.6 Analysis of Market W-Shaped Recovery Pattern
15.2.7 Analysis of Market U-Shaped Recovery Pattern
15.2.8 Analysis of Market L-Shaped Recovery Pattern
15.3 Mexico Pharmaceutical Contract Manufacturing Market Analysis
15.3.1 Mexico: Emerging Market Power
15.3.2 Healthcare – A Top Priority in Mexico
15.3.3 Strategic Management of High Expectations
15.3.4 Mexico: Pharma Contract Manufacturing Market
15.3.5 Analysis of Market Status Before COVID-19
15.3.6 Analysis of Market V-Shaped Recovery Pattern
15.3.7 Analysis of Market W-Shaped Recovery Pattern
15.3.8 Analysis of Market U-Shaped Recovery Pattern
15.3.9 Analysis of Market L-Shaped Recovery Pattern
15.4 Argentina Pharmaceutical Contract Manufacturing Market Analysis
15.4.1 Analysis of Market Status Before COVID-19
15.4.2 Analysis of Market V-Shaped Recovery Pattern
15.4.3 Analysis of Market W-Shaped Recovery Pattern
15.4.4 Analysis of Market U-Shaped Recovery Pattern
15.4.5 Analysis of Market L-Shaped Recovery Pattern
15.5 Rest of Latin America Pharmaceutical Contract Manufacturing Market Analysis
15.5.1 Analysis of Market Status Before COVID-19
15.5.2 Analysis of Market V-Shaped Recovery Pattern
15.5.3 Analysis of Market W-Shaped Recovery Pattern
15.5.4 Analysis of Market U-Shaped Recovery Pattern
15.5.5 Analysis of Market L-Shaped Recovery Pattern
15.6 Latin America Market Analysis by Product Category
15.6.1 Analysis of Market Status Before COVID-19
15.6.2 Analysis of Market V-Shaped Recovery Pattern
15.6.3 Analysis of Market W-Shaped Recovery Pattern
15.6.4 Analysis of Market U-Shaped Recovery Pattern
15.6.5 Analysis of Market L-Shaped Recovery Pattern
15.7 Latin America Market Analysis by Drug Type
15.7.1 Analysis of Market Status Before COVID-19
15.7.2 Analysis of Market V-Shaped Recovery Pattern
15.7.3 Analysis of Market W-Shaped Recovery Pattern
15.7.4 Analysis of Market U-Shaped Recovery Pattern
15.7.5 Analysis of Market L-Shaped Recovery Pattern
15.8 Latin America Market Analysis by API Contract Manufacturing
15.8.1 Analysis of Market Status Before COVID-19
15.8.2 Analysis of Market V-Shaped Recovery Pattern
15.8.3 Analysis of Market W-Shaped Recovery Pattern
15.8.4 Analysis of Market U-Shaped Recovery Pattern
15.8.5 Analysis of Market L-Shaped Recovery Pattern
15.9 Latin America Market Analysis by FDF Contract Manufacturing
15.9.1 Analysis of Market Status Before COVID-19
15.9.2 Analysis of Market V-Shaped Recovery Pattern
15.9.3 Analysis of Market W-Shaped Recovery Pattern
15.9.4 Analysis of Market U-Shaped Recovery Pattern
15.9.5 Analysis of Market L-Shaped Recovery Pattern
15.10 Latin America Market Analysis by End-User
15.10.1 Analysis of Market Status Before COVID-19
15.10.2 Analysis of Market V-Shaped Recovery Pattern
15.10.3 Analysis of Market W-Shaped Recovery Pattern
15.10.4 Analysis of Market U-Shaped Recovery Pattern
15.10.5 Analysis of Market L-Shaped Recovery Pattern
16 Competitive Landscape
16.1 Strategy and Tactics: The Importance of Outsourcing Wisely
16.2 Market Leaders
16.3 Market Shares
16.3.1 Bulk Drugs and APIs
16.3.2 Solid Dosage Forms
16.3.3 Liquid Dosage Forms
16.3.4 Semi-Solid Dosage Forms
16.4 Contract Research
16.4.1 Market Leaders
16.4.2 Market Shares
17 Key Player Profiles
17.1 Catalent Inc.
17.1.1 Company Details
17.1.2 Company Overview
17.1.3 Company Financial Analysis
17.1.4 Catalent Inc.: Company Revenue Analysis
17.2 Lonza Group AG
17.2.1 Company Details
17.2.2 Company Overview
17.2.3 Company Financial Analysis
17.2.4 Lonza Group AG: Company Revenue Analysis
17.3 Evonik Industries AG
17.3.1 Company Details
17.3.2 Company Overview
17.3.3 Company Financial Analysis
17.3.4 Evonik Industries AG: Company Revenue Analysis
17.4 Teva Pharmaceutical Industries Ltd
17.4.1 Company Details
17.4.2 Company Overview
17.4.3 Company Financial Analysis
17.4.4 Teva Pharmaceutical Industries Ltd: Company Revenue Analysis
17.5 Mylan NV
17.5.1 Company Details
17.5.2 Company Overview
17.5.3 Company Financial Analysis
17.5.4 Mylan NV: Company Revenue Analysis
17.6 AbbVie Inc
17.6.1 Company Details
17.6.2 Company Overview
17.6.3 Company Financial Analysis
17.6.4 AbbVie Inc: Company Revenue Analysis
17.7 Piramal Enterprises Ltd
17.7.1 Company Details
17.7.2 Company Overview
17.7.3 Company Financial Analysis
17.7.4 Piramal Enterprises Ltd: Company Revenue Analysis
17.8 Consort Medical plc
17.8.1 Company Details
17.8.2 Company Overview
17.8.3 Company Financial Analysis
17.8.4 Consort Medical plc: Company Revenue Analysis
17.9 Baxter International Inc
17.9.1 Company Details
17.9.2 Company Overview
17.9.3 Company Financial Analysis
17.9.4 Baxter International Inc: Company Revenue Analysis
17.10 Alkermes Plc
17.10.1 Company Details
17.10.2 Company Overview
17.10.3 Company Financial Analysis
17.10.4 Alkermes Plc: Company Revenue Analysis
17.11 Bayer AG
17.11.1 Company Details
17.11.2 Company Overview
17.11.3 Company Financial Analysis
17.11.4 Bayer AG: Company Revenue Analysis
17.12 GlaxoSmithKline plc
17.12.1 Company Details
17.12.2 Company Overview
17.12.3 Company Financial Analysis
17.12.4 GlaxoSmithKline plc: Company Revenue Analysis
17.13 NIPRO Corporation
17.13.1 Company Details
17.13.2 Company Overview
17.13.3 Company Financial Analysis
17.13.4 NIPRO Corporation: Company Revenue Analysis
18 Conclusion and Recommendations
18.1 Will Product Reformulation Drive Growth to 2030?
18.2 Demand for Biopharma Manufacturing Will Drive Growth 2020-2030
18.3 Demand Will Be Highest Among Developed-Market Clients
18.4 How Will Biotech Funding Impact the Pharma Contract Manufacturing Industry to 2030?
19 Glossary
List of Figures
Figure 3.1 Prominent Factors Affecting Growth of Pharmaceutical Contract Manufacturing Market
Figure 3.2 Market Drivers For Growth of Pharmaceutical Contract Manufacturing Market
Figure 3.3 Opportunities in the Global Pharmaceutical Contract Manufacturing Market
Figure 3.4 Growth Restrains in the Global Pharmaceutical Contract Manufacturing Market
Figure 3.5 SWOT Analysis of Pharmaceutical Contract Manufacturing Market
Figure 3.6 Porter’s Five Forces Analysis of Pharmaceutical Contract Manufacturing Market
Figure 5.1 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %)
Figure 5.2 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 5.3 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 5.4 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 5.5 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 5.6 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 5.7 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 5.8 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 5.9 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 5.10 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 5.11 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %)
Figure 5.12 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 5.13 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 5.14 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 5.15 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 5.16 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %)
Figure 5.17 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 5.18 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 5.19 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 5.20 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 5.21 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %)
Figure 5.22 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 5.23 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 5.24 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 5.25 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 5.26 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %)
Figure 5.27 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 5.28 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 5.29 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 5.30 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 5.31 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %)
Figure 5.32 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 5.33 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 5.34 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 5.35 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 6.1 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 6.2 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 6.3 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 6.4 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 6.5 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 6.6 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 6.7 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 6.8 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 6.9 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 6.10 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 7.1 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 7.2 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 7.3 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 7.4 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 7.5 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 7.6 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 7.7 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 7.8 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 7.9 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 7.10 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 8.1 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 8.2 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 8.3 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 8.4 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 8.5 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 8.6 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 8.7 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 8.8 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 8.9 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 8.10 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 8.11 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 8.12 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 8.13 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 8.14 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 8.15 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 9.1 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 9.2 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 9.3 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 9.4 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 9.5 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 9.6 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 9.7 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 9.8 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 9.9 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 9.10 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 9.11 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 9.12 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 9.13 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 9.14 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 9.15 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 9.16 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 9.17 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 9.18 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 9.19 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 9.20 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 10.1 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 10.2 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 10.3 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 10.4 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 10.5 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 10.6 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 10.7 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 10.8 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 10.9 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 10.10 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 10.11 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 10.12 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 10.13 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 10.14 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 10.15 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 10.16 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 10.17 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 10.18 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 10.19 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 10.20 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 11.1 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %)
Figure 11.2 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 11.3 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 11.4 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 11.5 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 11.6 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %)
Figure 11.7 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 11.8 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 11.9 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 11.10 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 11.11 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %)
Figure 11.12 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 11.13 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 11.14 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 11.15 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 11.16 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %)
Figure 11.17 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 11.18 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 11.19 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 11.20 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 11.21 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %)
Figure 11.22 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 11.23 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 11.24 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 11.25 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 11.26 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %)
Figure 11.27 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 11.28 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 11.29 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 11.30 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 12.1 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %)
Figure 12.2 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 12.3 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 12.4 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 12.5 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 12.6 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %)
Figure 12.7 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 12.8 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 12.9 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 12.10 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 12.11 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %)
Figure 12.12 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 12.13 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 12.14 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 12.15 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 12.16 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %)
Figure 12.17 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 12.18 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 12.19 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 12.20 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 12.21 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %)
Figure 12.22 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 12.23 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 12.24 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 12.25 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 12.26 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %)
Figure 12.27 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 12.28 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 12.29 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 12.30 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 13.1 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %)
Figure 13.2 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 13.3 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 13.4 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 13.5 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 13.6 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %)
Figure 13.7 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 13.8 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 13.9 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 13.10 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 13.11 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %)
Figure 13.12 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 13.13 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 13.14 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 13.15 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 13.16 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %)
Figure 13.17 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 13.18 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 13.19 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 13.20 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 13.21 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %)
Figure 13.22 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 13.23 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 13.24 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 13.25 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 13.26 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %)
Figure 13.27 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 13.28 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 13.29 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 13.30 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 14.1 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %)
Figure 14.2 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 14.3 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 14.4 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 14.5 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 14.6 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %)
Figure 14.7 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 14.8 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 14.9 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 14.10 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 14.11 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %)
Figure 14.12 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 14.13 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 14.14 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 14.15 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 14.16 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %)
Figure 14.17 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 14.18 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 14.19 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 14.20 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 14.21 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %)
Figure 14.22 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 14.23 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 14.24 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 14.25 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 14.26 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %)
Figure 14.27 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 14.28 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 13.29 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 14.30 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 15.1 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %)
Figure 15.2 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 15.3 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 15.4 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 15.5 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 15.6 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %)
Figure 15.7 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 15.8 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 15.9 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 15.10 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 15.11 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %)
Figure 15.12 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 15.13 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 15.14 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 15.15 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %)
Figure 15.16 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 15.17 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 15.18 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 15.19 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 15.20 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %)
Figure 15.21 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 15.22 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 15.23 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 15.24 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 15.25 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %)
Figure 15.26 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 15.27 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 15.28 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 15.29 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 17.1 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.2 Catalent Inc. Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.3 Catalent Inc. Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.4 Catalent Inc. Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.5 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.6 Lonza Group AG Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.7 Lonza Group AG Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.8 Lonza Group AG Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.9 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.10 Evonik Industries AG Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.11 Evonik Industries AG Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.12 Evonik Industries AG Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.13 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.14 Teva Pharmaceutical Industries Ltd Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.15 Teva Pharmaceutical Industries Ltd Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.16 Teva Pharmaceutical Industries Ltd Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.17 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.18 Mylan NV Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.19 Mylan NV Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.20 Mylan NV Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.21 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.22 AbbVie Inc Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.23 AbbVie Inc Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.24 AbbVie Inc Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.25 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.26 Piramal Enterprises Ltd Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.27 Piramal Enterprises Ltd Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.28 Piramal Enterprises Ltd Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.29 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.30 Consort Medical plc Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.31 Consort Medical plc Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.32 Consort Medical plc Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.33 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.34 Baxter International Inc Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.35 Baxter International Inc Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.36 Baxter International Inc Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.37 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.38 Alkermes Plc Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.39 Alkermes Plc Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.40 Alkermes Plc Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.41 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.42 Bayer AG Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.43 Bayer AG Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.44 Bayer AG Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.45 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.46 GlaxoSmithKline plc Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.47 GlaxoSmithKline plc Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.48 GlaxoSmithKline plc Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.49 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.50 NIPRO Corporation Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.51 NIPRO Corporation Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.52 NIPRO Corporation Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
List of Tables
Table 2.1 Global Pharmaceutical Contract Manufacturing Market Summary Table
Table 5.1 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 5.2 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 5.3 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 5.4 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 5.5 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 5.6 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 5.7 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 5.8 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 5.9 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 5.10 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 5.11 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 5.12 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 5.13 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 5.14 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 5.15 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 5.16 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 5.17 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 5.18 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 5.19 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 5.20 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 5.21 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 5.22 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 5.23 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 5.24 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 5.25 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 5.26 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 5.27 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 5.28 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 5.29 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 5.30 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 5.31 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 5.32 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 5.33 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 5.34 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 5.35 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 6.1 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 6.2 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 6.3 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 6.4 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 6.5 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 6.6 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 6.7 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 6.8 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 6.9 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 6.10 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 7.1 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 7.2 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 7.3 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 7.4 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 7.5 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 7.6 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 7.7 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 7.8 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 7.9 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 7.10 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.1 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 8.2 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.3 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.4 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.5 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.6 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 8.7 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.8 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.9 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.10 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.11 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 8.12 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.13 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.14 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.15 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.1 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 8.2 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.3 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.4 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.5 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.6 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 9.7 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.8 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.9 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.10 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.11 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 9.12 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.13 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.14 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.15 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.16 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 9.17 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.18 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.19 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.20 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.1 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 10.2 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.3 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.4 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.5 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.6 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 10.7 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.8 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.9 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.10 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.11 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 10.12 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.13 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.14 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.15 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.16 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 10.17 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.18 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.19 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.20 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.1 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 11.2 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.3 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.4 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.5 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.6 US Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 11.7 US Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.8 US Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.9 US Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.10 US Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.11 Canada Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 11.12 Canada Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.13 Canada Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.14 Canada Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.15 Canada Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.16 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 11.17 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.18 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.19 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.20 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.21 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 11.22 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.23 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.24 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.25 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.26 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 11.27 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.28 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.29 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.30 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.31 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 11.32 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.33 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.34 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.35 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.36 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 11.37 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.38 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.39 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.40 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.1 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.2 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.3 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.4 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.5 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.6 Germany Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.7 Germany Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.8 Germany Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.9 Germany Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.10 Germany Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.11 France Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.12 France Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.13 France Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.14 France Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.15 France Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.16 UK Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.17 UK Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.18 UK Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.19 UK Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.20 UK Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.21 Italy Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.22 Italy Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.23 Italy Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.24 Italy Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.25 Italy Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.26 Spain Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.27 Spain Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.28 Spain Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.29 Spain Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.30 Spain Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.31 Rest of Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.32 Rest of Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.33 Rest of Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.34 Rest of Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.35 Rest of Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.36 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.37 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.38 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.39 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.40 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.41 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.42 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.43 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.44 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.45 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.46 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.47 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.48 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.49 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.50 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.51 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.52 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.53 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.54 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.55 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.56 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.57 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.58 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.59 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.60 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.1 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.2 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.3 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.4 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.5 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.6 Japan Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.7 Japan Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.8 Japan Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.9 Japan Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.10 Japan Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.11 China Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.12 China Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.13 China Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.14 China Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.15 China Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.16 India Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.17 India Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.18 India Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.19 India Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.20 India Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.21 Korea Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.22 Korea Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.23 Korea Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.24 Korea Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.25 Korea Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.26 Australia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.27 Australia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.28 Australia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.29 Australia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.30 Australia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.31 Rest of Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.32 Rest of Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.33 Rest of Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.34 Rest of Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.35 Rest of Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.36 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.37 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.38 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.39 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.40 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.41 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.42 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.43 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.44 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.45 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.46 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.47 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.48 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.49 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.50 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.51 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.52 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.53 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.54 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.55 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.56 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.57 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.58 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.59 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.60 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.1 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.2 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.3 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.4 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.5 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.6 Turkey Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.7 Turkey Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.8 Turkey Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.9 Turkey Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.10 Turkey Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.11 Saudi Arabia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.12 Saudi Arabia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.13 Saudi Arabia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.14 Saudi Arabia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.15 Saudi Arabia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.16 South Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.17 South Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.18 South Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.19 South Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.20 South Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.21 UAE Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.22 UAE Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.23 UAE Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.24 UAE Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.25 UAE Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.26 Egypt Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.27 Egypt Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.28 Egypt Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.29 Egypt Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.30 Egypt Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.31 Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.32 Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.33 Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.34 Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.35 Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.36 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.37 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.38 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.39 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.40 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.41 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.42 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.43 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.44 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.45 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.46 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.47 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.48 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.49 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.50 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.51 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.52 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.53 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.54 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.55 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.56 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.57 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.58 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.59 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.60 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 15.1 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 15.2 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 15.3 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 15.4 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 15.5 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 15.6 Brazil Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 15.7 Brazil Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 15.8 Brazil Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 15.9 Brazil Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 15.10 Brazil Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.11 Mexico Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 15.12 Mexico Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 15.13 Mexico Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 15.14 Mexico Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 15.15 Mexico Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 15.16 Argentina Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 15.17 Argentina Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 15.18 Argentina Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 15.19 Argentina Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 15.20 Argentina Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 15.21 Rest of Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 15.22 Rest of Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 15.23 Rest of Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 15.24 Rest of Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 15.25 Rest of Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 15.26 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 15.27 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 15.28 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 15.29 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 15.30 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 15.31 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 15.32 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 15.33 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 15.34 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 15.35 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 15.36 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 15.37 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 15.38 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 15.39 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 15.40 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 15.41 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 15.42 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 15.43 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 15.44 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 15.45 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 15.46 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 15.47 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 15.48 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 15.49 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 16.1 Services Provided by Leading Pharmaceutical Contract Manufacturing Companies, 2019
Table 16.2 Global Market Share of Contract Manufacturing Companies Providing Bulk Drugs and APIs, 2019 (%)
Table 16.3 Global Market Share of Contract Manufacturing Companies Providing Solid Dosage Forms, 2019, (%)
Table 16.4 Global Market Share of Contract Manufacturing Companies Providing Nonsterile Liquid Dosage Forms, 2019 (%)
Table 16.5 Global Market Share of Contract Manufacturing Companies Providing Sterile Liquid Dosage Forms, 2019
Table 16.6 Global Market Share of Contract Manufacturing Companies Providing Semi-Solid Dosage Forms, 2019 (%)
Table 16.7 Services Provided by Leading Research Firms, 2019
Table 16.8 Global Market Share of Contract Research Companies, 2019
Table 16.9 Contracting Companies Offering Drug-Delivery Technologies and Systems, 2019
Table 17.1 Catalent Inc. (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.2 Catalent Inc. Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.3 Lonza Group AG (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.4 Lonza Group AG Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.5 Evonik Industries AG (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.6 Evonik Industries AG Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.7 Teva Pharmaceutical Industries Ltd (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.8 Teva Pharmaceutical Industries Ltd Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.9 Mylan NV (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.10 Mylan NV Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.11 AbbVie Inc (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.12 AbbVie Inc Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.13 Piramal Enterprises Ltd (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.14 Piramal Enterprises Ltd Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.15 Consort Medical plc (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.16 Consort Medical plc Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.17 Baxter International Inc (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.18 Baxter International Inc Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.19 Alkermes Plc (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.20 Alkermes Plc Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.21 Bayer AG (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.22 Bayer AG Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.23 GlaxoSmithKline plc (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.24 GlaxoSmithKline plc Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.25 NIPRO Corporation (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.26 NIPRO Corporation Company Revenue 2015-2019 (US$Mn, AGR %)
1.1 Scope of Report
1.2 Why You Should Buy This Report
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.6.1 Primary Research
1.6.2 Secondary Research
1.7 Market Evaluation & Forecasting Methodology
1.8 COIVD-19 Impact Recovery Pattern Analysis
1.8.1 V-Shaped Recovery
1.8.2 U-Shaped Recovery
1.8.3 W-Shaped Recovery
1.8.4 L-Shaped Recovery
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2 Executive Summary
2.1 Pharmaceutical Product Manufacturing Segment is Expected to Maintain its Dominance in the Global Market
2.2 COVID-19 Impact on Pharmaceutical Contract Manufacturing Market
3 Market Dynamics
3.1 Factors Affecting Growth
3.1.1 Product and Process Innovation
3.1.2 Continuing Focus on Productivity
3.1.3 Cost Savings
3.1.4 Risk Management
3.1.5 Stringent Regulations
3.1.6 Patent Expirations
3.1.7 Decreasing Research and Development Success Rates
3.2 Market Drivers
3.2.1 Increasing Demand of Biosimilars
3.2.2 Increased Focus on Orphan and Specialty Drugs
3.2.3 Generics: A Driver or Restraint?
3.2.4 Increasing Demand for Formulation Development Services
3.2.5 Bio/Pharmaceutical Manufacturers’ Move Toward Strategic Collaboration With Drug Delivery Technology Companies
3.3 Opportunities in the Global Market
3.3.1 Lack of Manufacturing and Packaging Capabilities
3.3.2 Pharma Companies Will Continue To Look For Ways To Cut Drug Costs
3.3.3 Need for New Drug Delivery Technologies
3.3.4 Chemical APIs Will Experience Resurgence after the Shift of Focus to Biological APIs
3.4 Growth Restrain
3.4.1 Backwards Integration for Generics Manufacturers
3.4.2 The US Generic Drug User Fee Act and API Manufacturing
3.5 Challenges in Contract Manufacturing
3.5.1 Challenges in Assessing the Market: Supply versus Demand
3.6 SWOT Analysis
3.7 Porter’s Five Forces Analysis
3.7.1 What are Porter Five (5) Forces
3.7.2 Threat of New Entrants (Low to Moderate)
3.7.3 Rivalry Among the Existing Players (High)
3.7.4 Bargaining Power of Suppliers (Low)
3.7.5 Threats from Substitute Products (Low to Moderate)
3.7.6 Bargaining Power of Buyers (High)
4 Global Pharmaceutical Contract Manufacturing Market
4.1 Industry Structure Overview
4.1.1 Pharmaceutical Landscape
4.1.2 Objectives of Outsourcing
4.1.3 Contract Manufacturing Types
4.1.4 Suitable Services Provider
4.1.5 Benefits of Outsourcing
4.1.6 Drawbacks of Outsourcing
4.1.7 Outsourcing
4.1.8 Core Capabilities of Contract Manufacturing Organization
4.1.9 Services Offered by Contract Manufacturing Organizations
5 Global Pharmaceutical Contract Manufacturing Market
5.1 Overview
5.1.1 Analysis of Market Status Before COVID-19
5.1.2 Analysis of Market V-Shaped Recovery Pattern
5.1.3 Analysis of Market W-Shaped Recovery Pattern
5.1.4 Analysis of Market U-Shaped Recovery Pattern
5.1.5 Analysis of Market L-Shaped Recovery Pattern
5.2 Regional Market Overview
5.2.1 Analysis of Market Status Before COVID-19
5.2.2 Analysis of Market V-Shaped Recovery Pattern
5.2.3 Analysis of Market W-Shaped Recovery Pattern
5.2.4 Analysis of Market U-Shaped Recovery Pattern
5.2.5 Analysis of Market L-Shaped Recovery Pattern
5.3 Product Category Market Overview
5.3.1 Analysis of Market Status Before COVID-19
5.3.2 Analysis of Market V-Shaped Recovery Pattern
5.3.3 Analysis of Market W-Shaped Recovery Pattern
5.3.4 Analysis of Market U-Shaped Recovery Pattern
5.3.5 Analysis of Market L-Shaped Recovery Pattern
5.4 Drug Type Market Overview
5.4.1 Analysis of Market Status Before COVID-19
5.4.2 Analysis of Market V-Shaped Recovery Pattern
5.4.3 Analysis of Market W-Shaped Recovery Pattern
5.4.4 Analysis of Market U-Shaped Recovery Pattern
5.4.5 Analysis of Market L-Shaped Recovery Pattern
5.5 API Contract Manufacturing Market Overview
5.5.1 Analysis of Market Status Before COVID-19
5.5.2 Analysis of Market V-Shaped Recovery Pattern
5.5.3 Analysis of Market W-Shaped Recovery Pattern
5.5.4 Analysis of Market U-Shaped Recovery Pattern
5.5.5 Analysis of Market L-Shaped Recovery Pattern
5.6 FDF Contract Manufacturing Market Overview
5.6.1 Analysis of Market Status Before COVID-19
5.6.2 Analysis of Market V-Shaped Recovery Pattern
5.6.3 Analysis of Market W-Shaped Recovery Pattern
5.6.4 Analysis of Market U-Shaped Recovery Pattern
5.6.5 Analysis of Market L-Shaped Recovery Pattern
5.7 End-User Market Overview
5.7.1 Analysis of Market Status Before COVID-19
5.7.2 Analysis of Market V-Shaped Recovery Pattern
5.7.3 Analysis of Market W-Shaped Recovery Pattern
5.7.4 Analysis of Market U-Shaped Recovery Pattern
5.7.5 Analysis of Market L-Shaped Recovery Pattern
6 Global Market Analysis by Product Category
6.1 Pharmaceutical Product Manufacturing Market Analysis by Region
6.1.1 Market Overview
6.1.2 Analysis of Market Status Before COVID-19
6.1.3 Analysis of Market V-Shaped Recovery Pattern
6.1.4 Analysis of Market W-Shaped Recovery Pattern
6.1.5 Analysis of Market U-Shaped Recovery Pattern
6.1.6 Analysis of Market L-Shaped Recovery Pattern
6.2 Biological Product Manufacturing Market Analysis by Region
6.2.1 Market Overview
6.2.2 Analysis of Market Status Before COVID-19
6.2.3 Analysis of Market V-Shaped Recovery Pattern
6.2.4 Analysis of Market W-Shaped Recovery Pattern
6.2.5 Analysis of Market U-Shaped Recovery Pattern
6.2.6 Analysis of Market L-Shaped Recovery Pattern
7 Global Market Analysis by Drug Type
7.1 Active Pharmaceutical Ingredient Manufacturing Market Analysis by Region
7.1.1 Market Overview
7.1.2 Analysis of Market Status Before COVID-19
7.1.3 Analysis of Market V-Shaped Recovery Pattern
7.1.4 Analysis of Market W-Shaped Recovery Pattern
7.1.5 Analysis of Market U-Shaped Recovery Pattern
7.1.6 Analysis of Market L-Shaped Recovery Pattern
7.2 Finished Dosage Form Products Manufacturing Market Analysis by Region
7.2.1 Analysis of Market Status Before COVID-19
7.2.2 Analysis of Market V-Shaped Recovery Pattern
7.2.3 Analysis of Market W-Shaped Recovery Pattern
7.2.4 Analysis of Market U-Shaped Recovery Pattern
7.2.5 Analysis of Market L-Shaped Recovery Pattern
8 Global Market Analysis by Active Pharmaceutical Ingredients Contract Manufacturing
8.1 API Small Molecule Manufacturing Market Analysis by Region
8.1.1 Analysis of Market Status Before COVID-19
8.1.2 Analysis of Market V-Shaped Recovery Pattern
8.1.3 Analysis of Market W-Shaped Recovery Pattern
8.1.4 Analysis of Market U-Shaped Recovery Pattern
8.1.5 Analysis of Market L-Shaped Recovery Pattern
8.2 API Large Molecule Manufacturing Market Analysis by Region
8.2.1 Analysis of Market Status Before COVID-19
8.2.2 Analysis of Market V-Shaped Recovery Pattern
8.2.3 Analysis of Market W-Shaped Recovery Pattern
8.2.4 Analysis of Market U-Shaped Recovery Pattern
8.2.5 Analysis of Market L-Shaped Recovery Pattern
8.3 High Potency API (HPAPI) Manufacturing Market Analysis by Region
8.3.1 Challenges and Opportunities in High Containment Manufacturing
8.3.2 Analysis of Market Status Before COVID-19
8.3.3 Analysis of Market V-Shaped Recovery Pattern
8.3.4 Analysis of Market W-Shaped Recovery Pattern
8.3.5 Analysis of Market U-Shaped Recovery Pattern
8.3.6 Analysis of Market L-Shaped Recovery Pattern
9 Global Market Analysis by Finished Dosage Form Contract Manufacturing
9.1 Solid Dose Formulation Manufacturing Market Analysis by Region
9.1.1 Market Overview
9.1.2 Analysis of Market Status Before COVID-19
9.1.3 Analysis of Market V-Shaped Recovery Pattern
9.1.4 Analysis of Market W-Shaped Recovery Pattern
9.1.5 Analysis of Market U-Shaped Recovery Pattern
9.1.6 Analysis of Market L-Shaped Recovery Pattern
9.2 Liquid Dose Formulation Manufacturing Market Analysis by Region
9.2.1 Market Overview
9.2.2 Nonsterile Formulations
9.2.3 Analysis of Market Status Before COVID-19
9.2.4 Analysis of Market V-Shaped Recovery Pattern
9.2.5 Analysis of Market W-Shaped Recovery Pattern
9.2.6 Analysis of Market U-Shaped Recovery Pattern
9.2.7 Analysis of Market L-Shaped Recovery Pattern
9.3 Injectable Dose Formulation Manufacturing Market Analysis by Region
9.3.1 Sterile Formulations
9.3.2 Analysis of Market Status Before COVID-19
9.3.3 Analysis of Market V-Shaped Recovery Pattern
9.3.4 Analysis of Market W-Shaped Recovery Pattern
9.3.5 Analysis of Market U-Shaped Recovery Pattern
9.3.6 Analysis of Market L-Shaped Recovery Pattern
9.4 Other FDF Dose Formulation Manufacturing Market Analysis by Region
9.4.1 Semi-Solid Dosage Forms
9.4.2 Advanced Drug Delivery Products
9.4.3 Market Overview
9.4.4 Analysis of Market Status Before COVID-19
9.4.5 Analysis of Market V-Shaped Recovery Pattern
9.4.6 Analysis of Market W-Shaped Recovery Pattern
9.4.7 Analysis of Market U-Shaped Recovery Pattern
9.4.8 Analysis of Market L-Shaped Recovery Pattern
10 Global Market Analysis by End-User
10.1 Big Pharmaceutical Contract Manufacturing Market Analysis by Region
10.1.1 Analysis of Market Status Before COVID-19
10.1.2 Analysis of Market V-Shaped Recovery Pattern
10.1.3 Analysis of Market W-Shaped Recovery Pattern
10.1.4 Analysis of Market U-Shaped Recovery Pattern
10.1.5 Analysis of Market L-Shaped Recovery Pattern
10.2 Small & Mid-size Pharmaceutical Contract Manufacturing Market Analysis by Region
10.2.1 Analysis of Market Status Before COVID-19
10.2.2 Analysis of Market V-Shaped Recovery Pattern
10.2.3 Analysis of Market W-Shaped Recovery Pattern
10.2.4 Analysis of Market U-Shaped Recovery Pattern
10.2.5 Analysis of Market L-Shaped Recovery Pattern
10.3 Generic Pharmaceutical Companies Contract Manufacturing Market Analysis by Region
10.3.1 Analysis of Market Status Before COVID-19
10.3.2 Analysis of Market V-Shaped Recovery Pattern
10.3.3 Analysis of Market W-Shaped Recovery Pattern
10.3.4 Analysis of Market U-Shaped Recovery Pattern
10.3.5 Analysis of Market L-Shaped Recovery Pattern
10.4 Other End-User Contract Manufacturing Market Analysis by Region
10.4.1 Analysis of Market Status Before COVID-19
10.4.2 Analysis of Market V-Shaped Recovery Pattern
10.4.3 Analysis of Market W-Shaped Recovery Pattern
10.4.4 Analysis of Market U-Shaped Recovery Pattern
10.4.5 Analysis of Market L-Shaped Recovery Pattern
11 North America Pharmaceutical Contract Manufacturing Market Analysis
11.1 North America Market in Terms of Value
11.1.1 Analysis of Market Status Before COVID-19
11.1.2 Analysis of Market V-Shaped Recovery Pattern
11.1.3 Analysis of Market W-Shaped Recovery Pattern
11.1.4 Analysis of Market U-Shaped Recovery Pattern
11.1.5 Analysis of Market L-Shaped Recovery Pattern
11.2 US Pharmaceutical Contract Manufacturing Market Analysis
11.2.1 Pharmaceutical Manufacturing in the US: Regulatory Oversight, 2019
11.2.2 Controlling Foreign Manufacturing Sites
11.2.3 Outsourcing and US Manufacturing Regulations
11.2.4 Increased Demand for Domestic API Manufacturing?
11.2.5 Analysis of Market Status Before COVID-19
11.2.6 Analysis of Market V-Shaped Recovery Pattern
11.2.7 Analysis of Market W-Shaped Recovery Pattern
11.2.8 Analysis of Market U-Shaped Recovery Pattern
11.2.9 Analysis of Market L-Shaped Recovery Pattern
11.3 Canada Pharmaceutical Contract Manufacturing Market Analysis
11.3.1 Analysis of Market Status Before COVID-19
11.3.2 Analysis of Market V-Shaped Recovery Pattern
11.3.3 Analysis of Market W-Shaped Recovery Pattern
11.3.4 Analysis of Market U-Shaped Recovery Pattern
11.3.5 Analysis of Market L-Shaped Recovery Pattern
11.4 North America Market Analysis by Product Category
11.4.1 Analysis of Market Status Before COVID-19
11.4.2 Analysis of Market V-Shaped Recovery Pattern
11.4.3 Analysis of Market W-Shaped Recovery Pattern
11.4.4 Analysis of Market U-Shaped Recovery Pattern
11.4.5 Analysis of Market L-Shaped Recovery Pattern
11.5 North America Market Analysis by Drug Type
11.5.1 Analysis of Market Status Before COVID-19
11.5.2 Analysis of Market V-Shaped Recovery Pattern
11.5.3 Analysis of Market W-Shaped Recovery Pattern
11.5.4 Analysis of Market U-Shaped Recovery Pattern
11.5.5 Analysis of Market L-Shaped Recovery Pattern
11.6 North America Market Analysis by API Contract Manufacturing
11.6.1 Analysis of Market Status Before COVID-19
11.6.2 Analysis of Market V-Shaped Recovery Pattern
11.6.3 Analysis of Market W-Shaped Recovery Pattern
11.6.4 Analysis of Market U-Shaped Recovery Pattern
11.6.5 Analysis of Market L-Shaped Recovery Pattern
11.7 North America Market Analysis by FDF Contract Manufacturing
11.7.1 Analysis of Market Status Before COVID-19
11.7.2 Analysis of Market V-Shaped Recovery Pattern
11.7.3 Analysis of Market W-Shaped Recovery Pattern
11.7.4 Analysis of Market U-Shaped Recovery Pattern
11.7.5 Analysis of Market L-Shaped Recovery Pattern
11.8 North America Market Analysis by End-User
11.8.1 Analysis of Market Status Before COVID-19
11.8.2 Analysis of Market V-Shaped Recovery Pattern
11.8.3 Analysis of Market W-Shaped Recovery Pattern
11.8.4 Analysis of Market U-Shaped Recovery Pattern
11.8.5 Analysis of Market L-Shaped Recovery Pattern
12 Europe Pharmaceutical Contract Manufacturing Market Analysis
12.1.1 The EU is the Leading Destination for Pharmaceutical Contract Manufacturing
12.1.2 Regulatory Aspects of Pharma Manufacturing in the EU
12.1.3 The European Commission Amends Annex 16
12.1.4 The Falsified Medicine Directive: Controlling API Imports
12.1.5 Biopharma Manufacturing Demand Will Rise
12.1.6 The EU Contract Manufacturing Market Forecast 2020-2030
12.2 Europe Market in Terms of Value
12.2.1 Analysis of Market Status Before COVID-19
12.2.2 Analysis of Market V-Shaped Recovery Pattern
12.2.3 Analysis of Market W-Shaped Recovery Pattern
12.2.4 Analysis of Market U-Shaped Recovery Pattern
12.2.5 Analysis of Market L-Shaped Recovery Pattern
12.3 Germany Pharmaceutical Contract Manufacturing Market Analysis
12.3.1 Germany: The Leading EU Destination for API and FDF Manufacturing
12.3.2 Demand for Contract Manufacturing in Germany
12.3.3 Analysis of Market Status Before COVID-19
12.3.4 Analysis of Market V-Shaped Recovery Pattern
12.3.5 Analysis of Market W-Shaped Recovery Pattern
12.3.6 Analysis of Market U-Shaped Recovery Pattern
12.3.7 Analysis of Market L-Shaped Recovery Pattern
12.4 France Pharmaceutical Contract Manufacturing Market Analysis
12.4.1 Analysis of Market Status Before COVID-19
12.4.2 Analysis of Market V-Shaped Recovery Pattern
12.4.3 Analysis of Market W-Shaped Recovery Pattern
12.4.4 Analysis of Market U-Shaped Recovery Pattern
12.4.5 Analysis of Market L-Shaped Recovery Pattern
12.5 UK Pharmaceutical Contract Manufacturing Market Analysis
12.5.1 Analysis of Market Status Before COVID-19
12.5.2 Analysis of Market V-Shaped Recovery Pattern
12.5.3 Analysis of Market W-Shaped Recovery Pattern
12.5.4 Analysis of Market U-Shaped Recovery Pattern
12.5.5 Analysis of Market L-Shaped Recovery Pattern
12.6 Italy Pharmaceutical Contract Manufacturing Market Analysis
12.6.1 Italy: Strong API Manufacturing Traditions
12.6.2 Revenue Forecast for the Italian Pharma Contract Manufacturing
12.6.3 Analysis of Market Status Before COVID-19
12.6.4 Analysis of Market V-Shaped Recovery Pattern
12.6.5 Analysis of Market W-Shaped Recovery Pattern
12.6.6 Analysis of Market U-Shaped Recovery Pattern
12.6.7 Analysis of Market L-Shaped Recovery Pattern
12.7 Spain Pharmaceutical Contract Manufacturing Market Analysis
12.7.1 Spain: How Will Demand for Manufacturing Services Grow?
12.7.2 Analysis of Market Status Before COVID-19
12.7.3 Analysis of Market V-Shaped Recovery Pattern
12.7.4 Analysis of Market W-Shaped Recovery Pattern
12.7.5 Analysis of Market U-Shaped Recovery Pattern
12.7.6 Analysis of Market L-Shaped Recovery Pattern
12.8 Rest of Europe Pharmaceutical Contract Manufacturing Market Analysis
12.8.1 Compliance with GMP in Russia
12.8.2 How Will Demand for Contract Manufacturing Grow in Russia to 2030?
12.8.3 Analysis of Market Status Before COVID-19
12.8.4 Analysis of Market V-Shaped Recovery Pattern
12.8.5 Analysis of Market W-Shaped Recovery Pattern
12.8.6 Analysis of Market U-Shaped Recovery Pattern
12.8.7 Analysis of Market L-Shaped Recovery Pattern
12.9 Europe Market Analysis by Product Category
12.9.1 Analysis of Market Status Before COVID-19
12.9.2 Analysis of Market V-Shaped Recovery Pattern
12.9.3 Analysis of Market W-Shaped Recovery Pattern
12.9.4 Analysis of Market U-Shaped Recovery Pattern
12.9.5 Analysis of Market L-Shaped Recovery Pattern
12.10 Europe Market Analysis by Drug Type
12.10.1 Analysis of Market Status Before COVID-19
12.10.2 Analysis of Market V-Shaped Recovery Pattern
12.10.3 Analysis of Market W-Shaped Recovery Pattern
12.10.4 Analysis of Market U-Shaped Recovery Pattern
12.10.5 Analysis of Market L-Shaped Recovery Pattern
12.11 Europe Market Analysis by API Contract Manufacturing
12.11.1 Analysis of Market Status Before COVID-19
12.11.2 Analysis of Market V-Shaped Recovery Pattern
12.11.3 Analysis of Market W-Shaped Recovery Pattern
12.11.4 Analysis of Market U-Shaped Recovery Pattern
12.11.5 Analysis of Market L-Shaped Recovery Pattern
12.12 Europe Market Analysis by FDF Contract Manufacturing
12.12.1 Analysis of Market Status Before COVID-19
12.12.2 Analysis of Market V-Shaped Recovery Pattern
12.12.3 Analysis of Market W-Shaped Recovery Pattern
12.12.4 Analysis of Market U-Shaped Recovery Pattern
12.12.5 Analysis of Market L-Shaped Recovery Pattern
12.13 Europe Market Analysis by End-User
12.13.1 Analysis of Market Status Before COVID-19
12.13.2 Analysis of Market V-Shaped Recovery Pattern
12.13.3 Analysis of Market W-Shaped Recovery Pattern
12.13.4 Analysis of Market U-Shaped Recovery Pattern
12.13.5 Analysis of Market L-Shaped Recovery Pattern
13 Asia-Pacific Pharmaceutical Contract Manufacturing Market Analysis
13.1.1 Demand Will Increase for Services in India and China
13.2 Asia-Pacific Market in Terms of Value
13.2.1 Analysis of Market Status Before COVID-19
13.2.2 Analysis of Market V-Shaped Recovery Pattern
13.2.3 Analysis of Market W-Shaped Recovery Pattern
13.2.4 Analysis of Market U-Shaped Recovery Pattern
13.2.5 Analysis of Market L-Shaped Recovery Pattern
13.3 Japan Pharmaceutical Contract Manufacturing Market Analysis
13.3.1 Pharmaceutical Manufacturing Regulations in Japan
13.3.2 The Pharmaceutical Affairs Law
13.3.3 Analysis of Market Status Before COVID-19
13.3.4 Analysis of Market V-Shaped Recovery Pattern
13.3.5 Analysis of Market W-Shaped Recovery Pattern
13.3.6 Analysis of Market U-Shaped Recovery Pattern
13.3.7 Analysis of Market L-Shaped Recovery Pattern
13.4 China Pharmaceutical Contract Manufacturing Market Analysis
13.4.1 Chinese Demand for Pharma Contract Manufacturing Services
13.4.2 Improved Manufacturing Regulations in China
13.4.3 Regulations for Excipients and Guidance for API Manufacturing
13.4.4 What Are the Consequences to Stricter Manufacturing Regulations in China?
13.4.5 Chinese CMOs Are Investing in Biopharma Manufacturing
13.4.6 China Pharma Contract Manufacturing Market
13.4.7 Analysis of Market Status Before COVID-19
13.4.8 Analysis of Market V-Shaped Recovery Pattern
13.4.9 Analysis of Market W-Shaped Recovery Pattern
13.4.10 Analysis of Market U-Shaped Recovery Pattern
13.4.11 Analysis of Market L-Shaped Recovery Pattern
13.5 India Pharmaceutical Contract Manufacturing Market Analysis
13.5.1 Regulatory Outlook for Indian Pharma Manufacturing
13.5.2 Stricter Quality Standards to Ensure Compliance with EU Rules
13.5.3 Domestic Manufacturing Dominates the Indian Pharma Market
13.5.4 Demand for Contract Manufacturing in India
13.5.5 Analysis of Market Status Before COVID-19
13.5.6 Analysis of Market V-Shaped Recovery Pattern
13.5.7 Analysis of Market W-Shaped Recovery Pattern
13.5.8 Analysis of Market U-Shaped Recovery Pattern
13.5.9 Analysis of Market L-Shaped Recovery Pattern
13.6 South Korea Pharmaceutical Contract Manufacturing Market Analysis
13.6.1 South Korea: Government Supported Growth
13.6.2 South Korea: Strict GMP Regulations
13.6.3 South Korea: Pharma Contract Manufacturing Market
13.6.4 Analysis of Market Status Before COVID-19
13.6.5 Analysis of Market V-Shaped Recovery Pattern
13.6.6 Analysis of Market W-Shaped Recovery Pattern
13.6.7 Analysis of Market U-Shaped Recovery Pattern
13.6.8 Analysis of Market L-Shaped Recovery Pattern
13.7 Australia Pharmaceutical Contract Manufacturing Market Analysis
13.7.1 Analysis of Market Status Before COVID-19
13.7.2 Analysis of Market V-Shaped Recovery Pattern
13.7.3 Analysis of Market W-Shaped Recovery Pattern
13.7.4 Analysis of Market U-Shaped Recovery Pattern
13.7.5 Analysis of Market L-Shaped Recovery Pattern
13.8 Rest of APAC Pharmaceutical Contract Manufacturing Market Analysis
13.8.1 Analysis of Market Status Before COVID-19
13.8.2 Analysis of Market V-Shaped Recovery Pattern
13.8.3 Analysis of Market W-Shaped Recovery Pattern
13.8.4 Analysis of Market U-Shaped Recovery Pattern
13.8.5 Analysis of Market L-Shaped Recovery Pattern
13.9 Asia-Pacific Market Analysis by Product Category
13.9.1 Analysis of Market Status Before COVID-19
13.9.2 Analysis of Market V-Shaped Recovery Pattern
13.9.3 Analysis of Market W-Shaped Recovery Pattern
13.9.4 Analysis of Market U-Shaped Recovery Pattern
13.9.5 Analysis of Market L-Shaped Recovery Pattern
13.10 Asia-Pacific Market Analysis by Drug Type
13.10.1 Analysis of Market Status Before COVID-19
13.10.2 Analysis of Market V-Shaped Recovery Pattern
13.10.3 Analysis of Market W-Shaped Recovery Pattern
13.10.4 Analysis of Market U-Shaped Recovery Pattern
13.10.5 Analysis of Market L-Shaped Recovery Pattern
13.11 Asia-Pacific Market Analysis by API Contract Manufacturing
13.11.1 Analysis of Market Status Before COVID-19
13.11.2 Analysis of Market V-Shaped Recovery Pattern
13.11.3 Analysis of Market W-Shaped Recovery Pattern
13.11.4 Analysis of Market U-Shaped Recovery Pattern
13.11.5 Analysis of Market L-Shaped Recovery Pattern
13.12 Asia-Pacific Market Analysis by FDF Contract Manufacturing
13.12.1 Analysis of Market Status Before COVID-19
13.12.2 Analysis of Market V-Shaped Recovery Pattern
13.12.3 Analysis of Market W-Shaped Recovery Pattern
13.12.4 Analysis of Market U-Shaped Recovery Pattern
13.12.5 Analysis of Market L-Shaped Recovery Pattern
13.13 Asia-Pacific Market Analysis by End-User
13.13.1 Analysis of Market Status Before COVID-19
13.13.2 Analysis of Market V-Shaped Recovery Pattern
13.13.3 Analysis of Market W-Shaped Recovery Pattern
13.13.4 Analysis of Market U-Shaped Recovery Pattern
13.13.5 Analysis of Market L-Shaped Recovery Pattern
14 Middle East & Africa Pharmaceutical Contract Manufacturing Market Analysis
14.1 Middle East & Africa Market in Terms of Value
14.1.1 Analysis of Market Status Before COVID-19
14.1.2 Analysis of Market V-Shaped Recovery Pattern
14.1.3 Analysis of Market W-Shaped Recovery Pattern
14.1.4 Analysis of Market U-Shaped Recovery Pattern
14.1.5 Analysis of Market L-Shaped Recovery Pattern
14.2 Turkey Pharmaceutical Contract Manufacturing Market Analysis
14.2.1 Turkey: Domestic Market to offer Huge Growth Opportunities
14.2.2 Turkey: An Important Hub for Global Pharma Companies
14.2.3 Drug Approvals Delaying Growth of the Turkey Pharma Market
14.2.4 Analysis of Market Status Before COVID-19
14.2.5 Analysis of Market V-Shaped Recovery Pattern
14.2.6 Analysis of Market W-Shaped Recovery Pattern
14.2.7 Analysis of Market U-Shaped Recovery Pattern
14.2.8 Analysis of Market L-Shaped Recovery Pattern
14.3 Saudi Arabia Pharmaceutical Contract Manufacturing Market Analysis
14.3.1 Analysis of Market Status Before COVID-19
14.3.2 Analysis of Market V-Shaped Recovery Pattern
14.3.3 Analysis of Market W-Shaped Recovery Pattern
14.3.4 Analysis of Market U-Shaped Recovery Pattern
14.3.5 Analysis of Market L-Shaped Recovery Pattern
14.4 South Africa Pharmaceutical Contract Manufacturing Market Analysis
14.4.1 Analysis of Market Status Before COVID-19
14.4.2 Analysis of Market V-Shaped Recovery Pattern
14.4.3 Analysis of Market W-Shaped Recovery Pattern
14.4.4 Analysis of Market U-Shaped Recovery Pattern
14.4.5 Analysis of Market L-Shaped Recovery Pattern
14.5 UAE Pharmaceutical Contract Manufacturing Market Analysis
14.5.1 Analysis of Market Status Before COVID-19
14.5.2 Analysis of Market V-Shaped Recovery Pattern
14.5.3 Analysis of Market W-Shaped Recovery Pattern
14.5.4 Analysis of Market U-Shaped Recovery Pattern
14.5.5 Analysis of Market L-Shaped Recovery Pattern
14.6 Egypt Pharmaceutical Contract Manufacturing Market Analysis
14.6.1 Analysis of Market Status Before COVID-19
14.6.2 Analysis of Market V-Shaped Recovery Pattern
14.6.3 Analysis of Market W-Shaped Recovery Pattern
14.6.4 Analysis of Market U-Shaped Recovery Pattern
14.6.5 Analysis of Market L-Shaped Recovery Pattern
14.7 Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market Analysis
14.7.1 Analysis of Market Status Before COVID-19
14.7.2 Analysis of Market V-Shaped Recovery Pattern
14.7.3 Analysis of Market W-Shaped Recovery Pattern
14.7.4 Analysis of Market U-Shaped Recovery Pattern
14.7.5 Analysis of Market L-Shaped Recovery Pattern
14.8 Middle East & Africa Market Analysis by Product Category
14.8.1 Analysis of Market Status Before COVID-19
14.8.2 Analysis of Market V-Shaped Recovery Pattern
14.8.3 Analysis of Market W-Shaped Recovery Pattern
14.8.4 Analysis of Market U-Shaped Recovery Pattern
14.8.5 Analysis of Market L-Shaped Recovery Pattern
14.9 Middle East & Africa Market Analysis by Drug Type
14.9.1 Analysis of Market Status Before COVID-19
14.9.2 Analysis of Market V-Shaped Recovery Pattern
14.9.3 Analysis of Market W-Shaped Recovery Pattern
14.9.4 Analysis of Market U-Shaped Recovery Pattern
14.9.5 Analysis of Market L-Shaped Recovery Pattern
14.10 Middle East & Africa Market Analysis by API Contract Manufacturing
14.10.1 Analysis of Market Status Before COVID-19
14.10.2 Analysis of Market V-Shaped Recovery Pattern
14.10.3 Analysis of Market W-Shaped Recovery Pattern
14.10.4 Analysis of Market U-Shaped Recovery Pattern
14.10.5 Analysis of Market L-Shaped Recovery Pattern
14.11 Middle East & Africa Market Analysis by FDF Contract Manufacturing
14.11.1 Analysis of Market Status Before COVID-19
14.11.2 Analysis of Market V-Shaped Recovery Pattern
14.11.3 Analysis of Market W-Shaped Recovery Pattern
14.11.4 Analysis of Market U-Shaped Recovery Pattern
14.11.5 Analysis of Market L-Shaped Recovery Pattern
14.12 Middle East & Africa Market Analysis by End-User
14.12.1 Analysis of Market Status Before COVID-19
14.12.2 Analysis of Market V-Shaped Recovery Pattern
14.12.3 Analysis of Market W-Shaped Recovery Pattern
14.12.4 Analysis of Market U-Shaped Recovery Pattern
14.12.5 Analysis of Market L-Shaped Recovery Pattern
15 Latin America Pharmaceutical Contract Manufacturing Market Analysis
15.1 Latin America Market in Terms of Value
15.1.1 Analysis of Market Status Before COVID-19
15.1.2 Analysis of Market V-Shaped Recovery Pattern
15.1.3 Analysis of Market W-Shaped Recovery Pattern
15.1.4 Analysis of Market U-Shaped Recovery Pattern
15.1.5 Analysis of Market L-Shaped Recovery Pattern
15.2 Brazil Pharmaceutical Contract Manufacturing Market Analysis
15.2.1 Pharmaceutical Manufacturing Regulations in Brazil
15.2.2 Brazil Imports Most of its APIs
15.2.3 Brazil: Pharma Contract Manufacturing Market
15.2.4 Analysis of Market Status Before COVID-19
15.2.5 Analysis of Market V-Shaped Recovery Pattern
15.2.6 Analysis of Market W-Shaped Recovery Pattern
15.2.7 Analysis of Market U-Shaped Recovery Pattern
15.2.8 Analysis of Market L-Shaped Recovery Pattern
15.3 Mexico Pharmaceutical Contract Manufacturing Market Analysis
15.3.1 Mexico: Emerging Market Power
15.3.2 Healthcare – A Top Priority in Mexico
15.3.3 Strategic Management of High Expectations
15.3.4 Mexico: Pharma Contract Manufacturing Market
15.3.5 Analysis of Market Status Before COVID-19
15.3.6 Analysis of Market V-Shaped Recovery Pattern
15.3.7 Analysis of Market W-Shaped Recovery Pattern
15.3.8 Analysis of Market U-Shaped Recovery Pattern
15.3.9 Analysis of Market L-Shaped Recovery Pattern
15.4 Argentina Pharmaceutical Contract Manufacturing Market Analysis
15.4.1 Analysis of Market Status Before COVID-19
15.4.2 Analysis of Market V-Shaped Recovery Pattern
15.4.3 Analysis of Market W-Shaped Recovery Pattern
15.4.4 Analysis of Market U-Shaped Recovery Pattern
15.4.5 Analysis of Market L-Shaped Recovery Pattern
15.5 Rest of Latin America Pharmaceutical Contract Manufacturing Market Analysis
15.5.1 Analysis of Market Status Before COVID-19
15.5.2 Analysis of Market V-Shaped Recovery Pattern
15.5.3 Analysis of Market W-Shaped Recovery Pattern
15.5.4 Analysis of Market U-Shaped Recovery Pattern
15.5.5 Analysis of Market L-Shaped Recovery Pattern
15.6 Latin America Market Analysis by Product Category
15.6.1 Analysis of Market Status Before COVID-19
15.6.2 Analysis of Market V-Shaped Recovery Pattern
15.6.3 Analysis of Market W-Shaped Recovery Pattern
15.6.4 Analysis of Market U-Shaped Recovery Pattern
15.6.5 Analysis of Market L-Shaped Recovery Pattern
15.7 Latin America Market Analysis by Drug Type
15.7.1 Analysis of Market Status Before COVID-19
15.7.2 Analysis of Market V-Shaped Recovery Pattern
15.7.3 Analysis of Market W-Shaped Recovery Pattern
15.7.4 Analysis of Market U-Shaped Recovery Pattern
15.7.5 Analysis of Market L-Shaped Recovery Pattern
15.8 Latin America Market Analysis by API Contract Manufacturing
15.8.1 Analysis of Market Status Before COVID-19
15.8.2 Analysis of Market V-Shaped Recovery Pattern
15.8.3 Analysis of Market W-Shaped Recovery Pattern
15.8.4 Analysis of Market U-Shaped Recovery Pattern
15.8.5 Analysis of Market L-Shaped Recovery Pattern
15.9 Latin America Market Analysis by FDF Contract Manufacturing
15.9.1 Analysis of Market Status Before COVID-19
15.9.2 Analysis of Market V-Shaped Recovery Pattern
15.9.3 Analysis of Market W-Shaped Recovery Pattern
15.9.4 Analysis of Market U-Shaped Recovery Pattern
15.9.5 Analysis of Market L-Shaped Recovery Pattern
15.10 Latin America Market Analysis by End-User
15.10.1 Analysis of Market Status Before COVID-19
15.10.2 Analysis of Market V-Shaped Recovery Pattern
15.10.3 Analysis of Market W-Shaped Recovery Pattern
15.10.4 Analysis of Market U-Shaped Recovery Pattern
15.10.5 Analysis of Market L-Shaped Recovery Pattern
16 Competitive Landscape
16.1 Strategy and Tactics: The Importance of Outsourcing Wisely
16.2 Market Leaders
16.3 Market Shares
16.3.1 Bulk Drugs and APIs
16.3.2 Solid Dosage Forms
16.3.3 Liquid Dosage Forms
16.3.4 Semi-Solid Dosage Forms
16.4 Contract Research
16.4.1 Market Leaders
16.4.2 Market Shares
17 Key Player Profiles
17.1 Catalent Inc.
17.1.1 Company Details
17.1.2 Company Overview
17.1.3 Company Financial Analysis
17.1.4 Catalent Inc.: Company Revenue Analysis
17.2 Lonza Group AG
17.2.1 Company Details
17.2.2 Company Overview
17.2.3 Company Financial Analysis
17.2.4 Lonza Group AG: Company Revenue Analysis
17.3 Evonik Industries AG
17.3.1 Company Details
17.3.2 Company Overview
17.3.3 Company Financial Analysis
17.3.4 Evonik Industries AG: Company Revenue Analysis
17.4 Teva Pharmaceutical Industries Ltd
17.4.1 Company Details
17.4.2 Company Overview
17.4.3 Company Financial Analysis
17.4.4 Teva Pharmaceutical Industries Ltd: Company Revenue Analysis
17.5 Mylan NV
17.5.1 Company Details
17.5.2 Company Overview
17.5.3 Company Financial Analysis
17.5.4 Mylan NV: Company Revenue Analysis
17.6 AbbVie Inc
17.6.1 Company Details
17.6.2 Company Overview
17.6.3 Company Financial Analysis
17.6.4 AbbVie Inc: Company Revenue Analysis
17.7 Piramal Enterprises Ltd
17.7.1 Company Details
17.7.2 Company Overview
17.7.3 Company Financial Analysis
17.7.4 Piramal Enterprises Ltd: Company Revenue Analysis
17.8 Consort Medical plc
17.8.1 Company Details
17.8.2 Company Overview
17.8.3 Company Financial Analysis
17.8.4 Consort Medical plc: Company Revenue Analysis
17.9 Baxter International Inc
17.9.1 Company Details
17.9.2 Company Overview
17.9.3 Company Financial Analysis
17.9.4 Baxter International Inc: Company Revenue Analysis
17.10 Alkermes Plc
17.10.1 Company Details
17.10.2 Company Overview
17.10.3 Company Financial Analysis
17.10.4 Alkermes Plc: Company Revenue Analysis
17.11 Bayer AG
17.11.1 Company Details
17.11.2 Company Overview
17.11.3 Company Financial Analysis
17.11.4 Bayer AG: Company Revenue Analysis
17.12 GlaxoSmithKline plc
17.12.1 Company Details
17.12.2 Company Overview
17.12.3 Company Financial Analysis
17.12.4 GlaxoSmithKline plc: Company Revenue Analysis
17.13 NIPRO Corporation
17.13.1 Company Details
17.13.2 Company Overview
17.13.3 Company Financial Analysis
17.13.4 NIPRO Corporation: Company Revenue Analysis
18 Conclusion and Recommendations
18.1 Will Product Reformulation Drive Growth to 2030?
18.2 Demand for Biopharma Manufacturing Will Drive Growth 2020-2030
18.3 Demand Will Be Highest Among Developed-Market Clients
18.4 How Will Biotech Funding Impact the Pharma Contract Manufacturing Industry to 2030?
19 Glossary
List of Figures
Figure 3.1 Prominent Factors Affecting Growth of Pharmaceutical Contract Manufacturing Market
Figure 3.2 Market Drivers For Growth of Pharmaceutical Contract Manufacturing Market
Figure 3.3 Opportunities in the Global Pharmaceutical Contract Manufacturing Market
Figure 3.4 Growth Restrains in the Global Pharmaceutical Contract Manufacturing Market
Figure 3.5 SWOT Analysis of Pharmaceutical Contract Manufacturing Market
Figure 3.6 Porter’s Five Forces Analysis of Pharmaceutical Contract Manufacturing Market
Figure 5.1 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %)
Figure 5.2 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 5.3 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 5.4 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 5.5 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 5.6 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 5.7 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 5.8 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 5.9 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 5.10 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 5.11 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %)
Figure 5.12 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 5.13 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 5.14 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 5.15 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 5.16 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %)
Figure 5.17 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 5.18 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 5.19 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 5.20 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 5.21 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %)
Figure 5.22 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 5.23 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 5.24 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 5.25 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 5.26 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %)
Figure 5.27 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 5.28 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 5.29 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 5.30 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 5.31 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %)
Figure 5.32 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 5.33 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 5.34 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 5.35 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 6.1 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 6.2 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 6.3 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 6.4 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 6.5 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 6.6 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 6.7 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 6.8 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 6.9 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 6.10 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 7.1 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 7.2 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 7.3 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 7.4 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 7.5 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 7.6 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 7.7 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 7.8 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 7.9 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 7.10 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 8.1 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 8.2 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 8.3 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 8.4 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 8.5 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 8.6 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 8.7 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 8.8 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 8.9 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 8.10 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 8.11 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 8.12 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 8.13 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 8.14 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 8.15 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 9.1 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 9.2 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 9.3 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 9.4 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 9.5 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 9.6 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 9.7 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 9.8 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 9.9 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 9.10 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 9.11 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 9.12 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 9.13 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 9.14 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 9.15 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 9.16 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 9.17 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 9.18 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 9.19 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 9.20 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 10.1 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 10.2 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 10.3 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 10.4 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 10.5 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 10.6 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 10.7 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 10.8 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 10.9 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 10.10 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 10.11 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 10.12 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 10.13 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 10.14 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 10.15 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 10.16 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %)
Figure 10.17 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 10.18 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 10.19 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 10.20 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 11.1 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %)
Figure 11.2 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 11.3 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 11.4 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 11.5 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 11.6 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %)
Figure 11.7 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 11.8 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 11.9 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 11.10 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 11.11 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %)
Figure 11.12 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 11.13 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 11.14 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 11.15 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 11.16 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %)
Figure 11.17 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 11.18 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 11.19 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 11.20 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 11.21 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %)
Figure 11.22 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 11.23 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 11.24 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 11.25 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 11.26 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %)
Figure 11.27 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 11.28 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 11.29 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 11.30 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 12.1 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %)
Figure 12.2 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 12.3 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 12.4 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 12.5 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 12.6 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %)
Figure 12.7 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 12.8 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 12.9 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 12.10 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 12.11 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %)
Figure 12.12 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 12.13 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 12.14 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 12.15 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 12.16 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %)
Figure 12.17 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 12.18 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 12.19 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 12.20 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 12.21 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %)
Figure 12.22 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 12.23 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 12.24 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 12.25 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 12.26 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %)
Figure 12.27 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 12.28 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 12.29 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 12.30 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 13.1 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %)
Figure 13.2 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 13.3 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 13.4 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 13.5 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 13.6 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %)
Figure 13.7 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 13.8 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 13.9 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 13.10 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 13.11 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %)
Figure 13.12 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 13.13 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 13.14 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 13.15 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 13.16 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %)
Figure 13.17 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 13.18 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 13.19 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 13.20 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 13.21 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %)
Figure 13.22 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 13.23 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 13.24 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 13.25 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 13.26 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %)
Figure 13.27 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 13.28 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 13.29 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 13.30 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 14.1 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %)
Figure 14.2 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 14.3 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 14.4 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 14.5 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 14.6 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %)
Figure 14.7 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 14.8 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 14.9 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 14.10 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 14.11 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %)
Figure 14.12 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 14.13 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 14.14 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 14.15 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 14.16 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %)
Figure 14.17 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 14.18 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 14.19 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 14.20 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 14.21 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %)
Figure 14.22 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 14.23 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 14.24 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 14.25 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 14.26 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %)
Figure 14.27 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 14.28 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 13.29 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 14.30 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 15.1 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %)
Figure 15.2 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 15.3 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 15.4 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 15.5 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 15.6 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %)
Figure 15.7 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 15.8 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 15.9 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 15.10 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 15.11 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %)
Figure 15.12 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 15.13 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 15.14 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 15.15 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %)
Figure 15.16 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 15.17 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 15.18 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 15.19 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 15.20 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %)
Figure 15.21 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 15.22 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 15.23 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 15.24 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 15.25 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %)
Figure 15.26 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 15.27 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 15.28 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 15.29 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 17.1 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.2 Catalent Inc. Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.3 Catalent Inc. Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.4 Catalent Inc. Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.5 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.6 Lonza Group AG Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.7 Lonza Group AG Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.8 Lonza Group AG Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.9 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.10 Evonik Industries AG Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.11 Evonik Industries AG Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.12 Evonik Industries AG Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.13 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.14 Teva Pharmaceutical Industries Ltd Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.15 Teva Pharmaceutical Industries Ltd Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.16 Teva Pharmaceutical Industries Ltd Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.17 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.18 Mylan NV Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.19 Mylan NV Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.20 Mylan NV Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.21 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.22 AbbVie Inc Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.23 AbbVie Inc Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.24 AbbVie Inc Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.25 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.26 Piramal Enterprises Ltd Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.27 Piramal Enterprises Ltd Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.28 Piramal Enterprises Ltd Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.29 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.30 Consort Medical plc Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.31 Consort Medical plc Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.32 Consort Medical plc Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.33 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.34 Baxter International Inc Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.35 Baxter International Inc Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.36 Baxter International Inc Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.37 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.38 Alkermes Plc Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.39 Alkermes Plc Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.40 Alkermes Plc Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.41 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.42 Bayer AG Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.43 Bayer AG Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.44 Bayer AG Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.45 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.46 GlaxoSmithKline plc Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.47 GlaxoSmithKline plc Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.48 GlaxoSmithKline plc Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.49 Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 17.50 NIPRO Corporation Company Operating Income Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.51 NIPRO Corporation Company Net Income/Loss Analysis 2015-2019 (US$Mn, AGR %)
Figure 17.52 NIPRO Corporation Company EBITDA Analysis 2015-2019 (US$Mn, AGR %)
List of Tables
Table 2.1 Global Pharmaceutical Contract Manufacturing Market Summary Table
Table 5.1 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 5.2 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 5.3 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 5.4 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 5.5 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 5.6 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 5.7 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 5.8 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 5.9 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 5.10 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 5.11 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 5.12 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 5.13 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 5.14 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 5.15 Global Pharmaceutical Contract Manufacturing Market by Product Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 5.16 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 5.17 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 5.18 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 5.19 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 5.20 Global Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 5.21 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 5.22 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 5.23 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 5.24 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 5.25 Global Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 5.26 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 5.27 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 5.28 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 5.29 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 5.30 Global Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 5.31 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 5.32 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 5.33 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 5.34 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 5.35 Global Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 6.1 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 6.2 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 6.3 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 6.4 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 6.5 Global Pharmaceutical Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 6.6 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 6.7 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 6.8 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 6.9 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 6.10 Global Biological Product Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 7.1 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 7.2 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 7.3 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 7.4 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 7.5 Global API Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 7.6 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 7.7 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 7.8 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 7.9 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 7.10 Global FDF Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.1 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 8.2 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.3 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.4 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.5 Global Small Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.6 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 8.7 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.8 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.9 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.10 Global Large Molecule Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 8.11 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 8.12 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 8.13 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.14 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 8.15 Global High Potency API (HPAPI) Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.1 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 8.2 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.3 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 8.4 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.5 Global Solid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.6 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 9.7 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.8 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.9 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.10 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.11 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 9.12 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.13 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.14 Global Liquid Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.15 Global Injectable Dose Formulation Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 9.16 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 9.17 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 9.18 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 9.19 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 9.20 Global Other FDFs Pharmaceutical Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.1 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 10.2 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.3 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.4 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.5 Global Big Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.6 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 10.7 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.8 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.9 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.10 Global Small & Mid-Size Pharma Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.11 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 10.12 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.13 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.14 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.15 Global Generic Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 10.16 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 10.17 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 10.18 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 10.19 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 10.20 Global Other Pharmaceutical Companies Contract Manufacturing Market by Region Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.1 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 11.2 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.3 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.4 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.5 North America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.6 US Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 11.7 US Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.8 US Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.9 US Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.10 US Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.11 Canada Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 11.12 Canada Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.13 Canada Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.14 Canada Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.15 Canada Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.16 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 11.17 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.18 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.19 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.20 North America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.21 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 11.22 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.23 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.24 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.25 North America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.26 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 11.27 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.28 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.29 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.30 North America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.31 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 11.32 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.33 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.34 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.35 North America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 11.36 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 11.37 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 11.38 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.39 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 11.40 North America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.1 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.2 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.3 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.4 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.5 Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.6 Germany Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.7 Germany Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.8 Germany Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.9 Germany Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.10 Germany Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.11 France Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.12 France Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.13 France Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.14 France Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.15 France Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.16 UK Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.17 UK Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.18 UK Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.19 UK Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.20 UK Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.21 Italy Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.22 Italy Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.23 Italy Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.24 Italy Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.25 Italy Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.26 Spain Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.27 Spain Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.28 Spain Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.29 Spain Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.30 Spain Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.31 Rest of Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.32 Rest of Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.33 Rest of Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.34 Rest of Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.35 Rest of Europe Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.36 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.37 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.38 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.39 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.40 Europe Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.41 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.42 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.43 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 11.44 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.45 Europe Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.46 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.47 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.48 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.49 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.50 Europe Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.51 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.52 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.53 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.54 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.55 Europe Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 12.56 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 12.57 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 12.58 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 12.59 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 12.60 Europe Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.1 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.2 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.3 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.4 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.5 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.6 Japan Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.7 Japan Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.8 Japan Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.9 Japan Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.10 Japan Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.11 China Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.12 China Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.13 China Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.14 China Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.15 China Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.16 India Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.17 India Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.18 India Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.19 India Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.20 India Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.21 Korea Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.22 Korea Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.23 Korea Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.24 Korea Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.25 Korea Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.26 Australia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.27 Australia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.28 Australia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.29 Australia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.30 Australia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.31 Rest of Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.32 Rest of Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.33 Rest of Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.34 Rest of Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.35 Rest of Asia-Pacific Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.36 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.37 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.38 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.39 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.40 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.41 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.42 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.43 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.44 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.45 Asia-Pacific Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.46 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.47 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.48 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.49 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.50 Asia-Pacific Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.51 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.52 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.53 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.54 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.55 Asia-Pacific Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 13.56 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 13.57 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 13.58 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 13.59 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 13.60 Asia-Pacific Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.1 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.2 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.3 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.4 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.5 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.6 Turkey Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.7 Turkey Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.8 Turkey Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.9 Turkey Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.10 Turkey Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.11 Saudi Arabia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.12 Saudi Arabia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.13 Saudi Arabia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.14 Saudi Arabia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.15 Saudi Arabia Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.16 South Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.17 South Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.18 South Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.19 South Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.20 South Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.21 UAE Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.22 UAE Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.23 UAE Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.24 UAE Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.25 UAE Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.26 Egypt Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.27 Egypt Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.28 Egypt Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.29 Egypt Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.30 Egypt Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.31 Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.32 Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.33 Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.34 Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.35 Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.36 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.37 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.38 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.39 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.40 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.41 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.42 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.43 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.44 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.45 Middle East & Africa Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.46 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.47 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.48 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.49 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.50 Middle East & Africa Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.51 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.52 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.53 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.54 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.55 Middle East & Africa Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.56 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 14.57 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 14.58 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 14.59 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 14.60 Middle East & Africa Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 15.1 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 15.2 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 15.3 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 15.4 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 15.5 Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 15.6 Brazil Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 15.7 Brazil Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 15.8 Brazil Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 15.9 Brazil Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 15.10 Brazil Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 14.11 Mexico Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 15.12 Mexico Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 15.13 Mexico Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 15.14 Mexico Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 15.15 Mexico Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 15.16 Argentina Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 15.17 Argentina Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 15.18 Argentina Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 15.19 Argentina Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 15.20 Argentina Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 15.21 Rest of Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 15.22 Rest of Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 15.23 Rest of Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 15.24 Rest of Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 15.25 Rest of Latin America Pharmaceutical Contract Manufacturing Market by Value Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 15.26 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 15.27 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 15.28 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 15.29 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 15.30 Latin America Pharmaceutical Contract Manufacturing Market by Category Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 15.31 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 15.32 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 15.33 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 15.34 Latin America Pharmaceutical Contract Manufacturing Market by Drug Type Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 15.35 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 15.36 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 15.37 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 15.38 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 15.39 Latin America Pharmaceutical Contract Manufacturing Market by API Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 15.40 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 15.41 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 15.42 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 15.43 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 15.44 Latin America Pharmaceutical Contract Manufacturing Market by FDF Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 15.45 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 15.46 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 15.47 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 15.48 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 15.49 Latin America Pharmaceutical Contract Manufacturing Market by End-User Forecast 2020-2030 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 16.1 Services Provided by Leading Pharmaceutical Contract Manufacturing Companies, 2019
Table 16.2 Global Market Share of Contract Manufacturing Companies Providing Bulk Drugs and APIs, 2019 (%)
Table 16.3 Global Market Share of Contract Manufacturing Companies Providing Solid Dosage Forms, 2019, (%)
Table 16.4 Global Market Share of Contract Manufacturing Companies Providing Nonsterile Liquid Dosage Forms, 2019 (%)
Table 16.5 Global Market Share of Contract Manufacturing Companies Providing Sterile Liquid Dosage Forms, 2019
Table 16.6 Global Market Share of Contract Manufacturing Companies Providing Semi-Solid Dosage Forms, 2019 (%)
Table 16.7 Services Provided by Leading Research Firms, 2019
Table 16.8 Global Market Share of Contract Research Companies, 2019
Table 16.9 Contracting Companies Offering Drug-Delivery Technologies and Systems, 2019
Table 17.1 Catalent Inc. (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.2 Catalent Inc. Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.3 Lonza Group AG (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.4 Lonza Group AG Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.5 Evonik Industries AG (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.6 Evonik Industries AG Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.7 Teva Pharmaceutical Industries Ltd (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.8 Teva Pharmaceutical Industries Ltd Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.9 Mylan NV (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.10 Mylan NV Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.11 AbbVie Inc (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.12 AbbVie Inc Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.13 Piramal Enterprises Ltd (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.14 Piramal Enterprises Ltd Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.15 Consort Medical plc (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.16 Consort Medical plc Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.17 Baxter International Inc (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.18 Baxter International Inc Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.19 Alkermes Plc (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.20 Alkermes Plc Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.21 Bayer AG (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.22 Bayer AG Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.23 GlaxoSmithKline plc (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.24 GlaxoSmithKline plc Company Revenue 2015-2019 (US$Mn, AGR %)
Table 17.25 NIPRO Corporation (Executive Leadership, Company Type, Total Company Revenue US$Mn, Headquarters, Website)
Table 17.26 NIPRO Corporation Company Revenue 2015-2019 (US$Mn, AGR %)
Companies Profiled in the Report
AbbVie Inc
Alkermes Plc
Baxter International Inc
Bayer AG
Catalent Inc.
Consort Medical plc
Evonik Industries AG
GlaxoSmithKline plc
Lonza Group AG
Mylan NV
NIPRO CORPORATION
Piramal Enterprises Ltd
Teva Pharmaceutical Industries Ltd
List of Companies Mentioned in the Report
AbbVie
Actavis
ADC Biotechnology
Aegerion Pharmaceuticals
Aenova Group
Aesica Pharma
Agensys
Agila Specialties
Ajinomoto Althea Inc
Alexion Pharmaceuticals
Almac Group
Althea Technologies
AMRI (Albany Molecular Research Inc)
API Corporation (APIC)
Aspen Pharmacare
Astellas
AstraZeneca
Banner Life Sciences
Banner Pharmacaps
Baring Private Equity Asia
Bausch & Lomb
Bayer Healthcare
Ben Venue Laboratories
Bend Research
Biogen Idec
BioIndustry Association (BIA)
Biotest
Blackstone Group
Boehringer Ingelheim
Boehringer Ingelheim BioXcellence
Bristol-Myers Squibb Company
Bushu Pharmaceuticals
Cambrex
Cambridge Major Laboratories
Catalent Pharma Solutions
Cedarburg Hauser
Cell Therapy Catapult
Celldex Therapeutics
Celltrion
Cenexi
Chemisch-Pharmazeutisches Laboratorium Ravensburg
Chemtrix
China FDA (CFDA)
Cipla
Cook Pharmica
CordenPharma
CTC Bio
Daito Pharmaceutical
Delpharm
Dishman Pharmaceuticals
DPx Fine Chemicals
DPx Holdings B.V.
Dr. Reddy’s Laboratories
DSP (DSM Sinochem Pharmaceuticals)
Eisai
Eli Lilly
Esteve Quimica
Euticals
Evonik Degussa
Famar
Fareva
FUJIFILM Diosynth Biotechnologies,
G-CON
Gallus Biopharmaceutical, LLC.
GEA Pharma-Systems
Genentech
GlaxoSmithKline (GSK)
Granules India
Haupt Pharma
Hexal
Hospira
Hospira One2One
ImmunoGen
Immunomedics
Indian Pharmaceutical Alliance
Innovent Biologics
IRIX Pharmaceuticals
Janssen
JK Pharmaceutical
Johnson & Johnson
Knowledge Transfer Network (KTN)
Lonza
Lupin
Marinopoulos Group
Matrix Laboratories
Medice
Medichem
Merck & Co.
Micron Technologies
Millennium
Mitsui & Co
Momenta Pharmaceuticals
Mylan
Neuland Laboratories
NICE Insight
NPS Pharmaceuticals
Nycomed
Orchid Chemicals & Pharmaceuticals
Oxford Biomedica
Patheon
Patheon Biologics
Pfizer
Pharmapak Technologies
Piramal Pharma Solutions
Progenics
Quintiles
Recepta Biopharma
Recipharm
Redwood Bioscience
Rentschler Biotechnologie
Roche
Royal DSM
SAFC
SafeBridge
Samsung Bioepis
Samsung BioLogics
Sandoz
Sanofi
Seattle Genetics
Shandong Xinhua
ShangPharma
Shire
Siegfried AG
Sigmar Italia
SMS Pharmaceuticals
Solvias AG
Speedel
Stada
Stem CentRx
Stevenage Bioscience Catalyst
Takeda
Temmler Group
Teva API
Thermo Fisher Scientific
UMN Pharma
UNIGEN
Valeant Pharmaceuticals
Valerion Therapeutics, LLC.
Vetter Pharma-Fertigung GmbH
Vivante GMP Solutions
West Pharmaceutical Services
WuXi PharmaTech
Zhangjiang Biotech & Pharmaceutical Base Company
Zhejiang Jiang Yuan Tang Biotechnology
List of Organizations Mentioned in the Report
Agência Nacional de Vigilância Sanitária (ANVISA)
Asociación Española de Fabricantes de Productos de Química Fina (AFAQUIM)
Associação Brasileira da Indústria Farmoquímica e de Insumos Farmacêuticos (ABIQUIFI)
Association of British Pharmaceutical Industry (ABPI)
Central Drugs Standard Control Organization (CDSCO)
Department of Health and Family Welfare
Development and Reform Commission (NDRC)
European Commission
European Medicines Agency (EMA)
Food and Drug Administration (US FDA)
Indian Drug Manufacturer’s Association (IDMA)
International Society of Pharmaceutical Engineering (IPSE)
Korea Food and Drug Administration (KFDA)
Korea Pharmaceutical Manufacturer’s Association (KPMA)
Medicines and Healthcare Products Regulatory Agency (MHRA)
Medicines Manufacturing Industry Partnership (MMIP)
Ministry of Health (MOH)
Ministry of Health, Labor and Welfare (MHLW)
Ministry of Industry and Information Technology (MIIT)
Pharmaceutical and Medical Devices Agency (PMDA)
World Health Organization (WHO)
AbbVie Inc
Alkermes Plc
Baxter International Inc
Bayer AG
Catalent Inc.
Consort Medical plc
Evonik Industries AG
GlaxoSmithKline plc
Lonza Group AG
Mylan NV
NIPRO CORPORATION
Piramal Enterprises Ltd
Teva Pharmaceutical Industries Ltd
List of Companies Mentioned in the Report
AbbVie
Actavis
ADC Biotechnology
Aegerion Pharmaceuticals
Aenova Group
Aesica Pharma
Agensys
Agila Specialties
Ajinomoto Althea Inc
Alexion Pharmaceuticals
Almac Group
Althea Technologies
AMRI (Albany Molecular Research Inc)
API Corporation (APIC)
Aspen Pharmacare
Astellas
AstraZeneca
Banner Life Sciences
Banner Pharmacaps
Baring Private Equity Asia
Bausch & Lomb
Bayer Healthcare
Ben Venue Laboratories
Bend Research
Biogen Idec
BioIndustry Association (BIA)
Biotest
Blackstone Group
Boehringer Ingelheim
Boehringer Ingelheim BioXcellence
Bristol-Myers Squibb Company
Bushu Pharmaceuticals
Cambrex
Cambridge Major Laboratories
Catalent Pharma Solutions
Cedarburg Hauser
Cell Therapy Catapult
Celldex Therapeutics
Celltrion
Cenexi
Chemisch-Pharmazeutisches Laboratorium Ravensburg
Chemtrix
China FDA (CFDA)
Cipla
Cook Pharmica
CordenPharma
CTC Bio
Daito Pharmaceutical
Delpharm
Dishman Pharmaceuticals
DPx Fine Chemicals
DPx Holdings B.V.
Dr. Reddy’s Laboratories
DSP (DSM Sinochem Pharmaceuticals)
Eisai
Eli Lilly
Esteve Quimica
Euticals
Evonik Degussa
Famar
Fareva
FUJIFILM Diosynth Biotechnologies,
G-CON
Gallus Biopharmaceutical, LLC.
GEA Pharma-Systems
Genentech
GlaxoSmithKline (GSK)
Granules India
Haupt Pharma
Hexal
Hospira
Hospira One2One
ImmunoGen
Immunomedics
Indian Pharmaceutical Alliance
Innovent Biologics
IRIX Pharmaceuticals
Janssen
JK Pharmaceutical
Johnson & Johnson
Knowledge Transfer Network (KTN)
Lonza
Lupin
Marinopoulos Group
Matrix Laboratories
Medice
Medichem
Merck & Co.
Micron Technologies
Millennium
Mitsui & Co
Momenta Pharmaceuticals
Mylan
Neuland Laboratories
NICE Insight
NPS Pharmaceuticals
Nycomed
Orchid Chemicals & Pharmaceuticals
Oxford Biomedica
Patheon
Patheon Biologics
Pfizer
Pharmapak Technologies
Piramal Pharma Solutions
Progenics
Quintiles
Recepta Biopharma
Recipharm
Redwood Bioscience
Rentschler Biotechnologie
Roche
Royal DSM
SAFC
SafeBridge
Samsung Bioepis
Samsung BioLogics
Sandoz
Sanofi
Seattle Genetics
Shandong Xinhua
ShangPharma
Shire
Siegfried AG
Sigmar Italia
SMS Pharmaceuticals
Solvias AG
Speedel
Stada
Stem CentRx
Stevenage Bioscience Catalyst
Takeda
Temmler Group
Teva API
Thermo Fisher Scientific
UMN Pharma
UNIGEN
Valeant Pharmaceuticals
Valerion Therapeutics, LLC.
Vetter Pharma-Fertigung GmbH
Vivante GMP Solutions
West Pharmaceutical Services
WuXi PharmaTech
Zhangjiang Biotech & Pharmaceutical Base Company
Zhejiang Jiang Yuan Tang Biotechnology
List of Organizations Mentioned in the Report
Agência Nacional de Vigilância Sanitária (ANVISA)
Asociación Española de Fabricantes de Productos de Química Fina (AFAQUIM)
Associação Brasileira da Indústria Farmoquímica e de Insumos Farmacêuticos (ABIQUIFI)
Association of British Pharmaceutical Industry (ABPI)
Central Drugs Standard Control Organization (CDSCO)
Department of Health and Family Welfare
Development and Reform Commission (NDRC)
European Commission
European Medicines Agency (EMA)
Food and Drug Administration (US FDA)
Indian Drug Manufacturer’s Association (IDMA)
International Society of Pharmaceutical Engineering (IPSE)
Korea Food and Drug Administration (KFDA)
Korea Pharmaceutical Manufacturer’s Association (KPMA)
Medicines and Healthcare Products Regulatory Agency (MHRA)
Medicines Manufacturing Industry Partnership (MMIP)
Ministry of Health (MOH)
Ministry of Health, Labor and Welfare (MHLW)
Ministry of Industry and Information Technology (MIIT)
Pharmaceutical and Medical Devices Agency (PMDA)
World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Pharmaceutical Contract Manufacturing Market Report 2020-2030Related reports
Asthma & COPD Therapies Market Report 2020-2030
Increasing pollution in emerging economies has resulted in degradation of air quality which is one of the major reasons for...Full DetailsPublished: 10 August 2020Biopharmaceuticals Excipients Market 2020-2030
The biopharmaceuticals excipients market is expected to grow at a CAGR of 12.2%.
...Full DetailsPublished: 15 April 2020Global Osteoporosis Pharmaceutical and Nutraceutical Market Report 2020-2030
Our 338-page report that includes 160 tables and 134 figures throws light on the pharmaceutical and nutraceutical market, the current...
Full DetailsPublished: 01 May 2020Pharma Wholesale and Distribution Market Forecasts 2020-2030
The pharma wholesale and distribution market is estimated to grow at a CAGR of 5% in the first half of...Full DetailsPublished: 30 September 2019Clinical Trial Supply and Logistics Market for Pharma 2020-2030
The global clinical trial supply and logistics market for pharma is estimated to have reach $10.3bn in 2019, dominated by...
Full DetailsPublished: 24 April 2020Global Contract Research Organisations (CROs) Market Report Forecasts 2020-2030
Visiongain assesses that the clinical research organizations (CROs) market will generate revenues of $38.0 billion in 2020.
...Full DetailsPublished: 12 February 2020Global Pre-Filled Syringes Market Forecast 2019-2029
The global pre-filled syringes market was valued at $9.8bn in 2018. This market is estimated to grow at a CAGR...
Full DetailsPublished: 31 January 2019Generic Drugs Market Report 2020-2030
Reduction in healthcare expenditure by generic medicines has been acknowledged for a long time. Multiple studies have proven that substituting...
Full DetailsPublished: 03 July 2020Biological Drug API Manufacturing Services World Industry and Market Forecast to 2029
The biological drug API manufacturing market is estimated to grow at a CAGR of 9.5% in the first half of...Full DetailsPublished: 07 November 2019Automation in Biopharma Industry 2020-2030
The automation in biopharma industry market is estimated to grow at a CAGR of 4.3% over the forecast period.
...Full DetailsPublished: 30 April 2020
Download sample pages
Complete the form below to download your free sample pages for Pharmaceutical Contract Manufacturing Market Report 2020-2030Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Bioreactors Market Report 2023-2033
The global Bioreactors market was estimated to be valued at US$ 9,9770.0 million in 2023 and is expected to register a CAGR of 12.2% from 2023 to 2033.
29 September 2023
Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033
The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.
27 September 2023
Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033
The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.
25 September 2023
Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033
The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.
21 September 2023
